[
  {
    "id": "PHARM-0001",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antipsychotic (atypical)",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting olanzapine? Select all that apply.",
    "choices": [
      "Store all medications in the bathroom medicine cabinet",
      "Stop the medication when symptoms improve",
      "report uncontrolled movements",
      "Keep an updated medication list and share it at every visit",
      "Share prescription medications with family members if they have similar symptoms",
      "monitor diet/exercise"
    ],
    "answer": [
      "report uncontrolled movements",
      "Keep an updated medication list and share it at every visit",
      "monitor diet/exercise"
    ],
    "rationale": "Teaching for olanzapine must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: report uncontrolled movements, monitor diet/exercise.",
    "choice_rationales": {
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "report uncontrolled movements": "Correct—supports safe self-management and reduces risk.",
      "Keep an updated medication list and share it at every visit": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "monitor diet/exercise": "Correct—supports safe self-management and reduces risk."
    },
    "case": {
      "tabs": {
        "case_study": "Antipsychotic (atypical) (olanzapine): scenario involves acute mania.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start olanzapine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0002",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Thyroid hormone",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the levothyroxine order?",
    "choices": [
      "Verify the order, allergies, and two patient identifiers before administration",
      "Ask the family to decide whether the client wants the medication today",
      "Give the medication first and then check the client’s vitals",
      "Skip patient education because the medication is routine"
    ],
    "answer": "Verify the order, allergies, and two patient identifiers before administration",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering levothyroxine.",
    "choice_rationales": {
      "Verify the order, allergies, and two patient identifiers before administration": "Correct—this action prevents a medication error and aligns with safe administration standards.",
      "Ask the family to decide whether the client wants the medication today": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Give the medication first and then check the client’s vitals": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Skip patient education because the medication is routine": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment."
    },
    "case": {
      "tabs": {
        "case_study": "Thyroid hormone (levothyroxine): scenario involves hypothyroidism.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0003",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Direct oral anticoagulant",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering apixaban requires immediate action?",
    "choices": [
      "bleeding",
      "dry mouth",
      "sleepiness after taking the dose",
      "transient nausea"
    ],
    "answer": "bleeding",
    "rationale": "High-risk adverse reactions to apixaban include bleeding. The nurse must respond to bleeding immediately to prevent deterioration.",
    "choice_rationales": {
      "bleeding": "Correct—bleeding is a serious adverse effect associated with apixaban and can progress rapidly if unaddressed.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Direct oral anticoagulant (apixaban): scenario involves DVT/PE prevention.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0004",
    "bank": "Pharmacology",
    "topic": "Pharmacology - NSAID",
    "system": "Musculoskeletal",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving ibuprofen. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Avoid documenting to prevent alarming the client",
      "Document the reaction and update the allergy list per policy",
      "Offer only ice chips and reassess in 6 hours",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Give the next dose early to overcome the reaction"
    ],
    "answer": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Give the next dose early to overcome the reaction": "Incorrect—unsafe and does not manage the reaction."
    },
    "case": {
      "tabs": {
        "case_study": "NSAID (ibuprofen): scenario involves acute musculoskeletal pain.",
        "vitals": "epigastric burning, HR 102, BP 128/78",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0005",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Anti-emetic",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering ondansetron, which findings should the nurse monitor closely for potential complications? Select all that apply.",
    "choices": [
      "QT prolongation",
      "dry skin in winter",
      "mild hunger",
      "constipation",
      "headache",
      "mild thirst"
    ],
    "answer": [
      "QT prolongation",
      "constipation",
      "headache"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of ondansetron: QT prolongation, constipation, headache.",
    "choice_rationales": {
      "QT prolongation": "Correct—known complication/adverse effect requiring surveillance.",
      "dry skin in winter": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "mild hunger": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "constipation": "Correct—known complication/adverse effect requiring surveillance.",
      "headache": "Correct—known complication/adverse effect requiring surveillance.",
      "mild thirst": "Incorrect—non-specific, not a priority adverse effect for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "Anti-emetic (ondansetron): scenario involves postop nausea.",
        "vitals": "N/V, HR 98, BP 122/74, dry mucosa",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0006",
    "bank": "Pharmacology",
    "topic": "Pharmacology - NSAID",
    "system": "Musculoskeletal",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with ibuprofen?",
    "choices": [
      "alcohol use with ibuprofen",
      "saline nasal spray with ibuprofen",
      "calcium carbonate with ibuprofen",
      "acetaminophen (standard dosing) with ibuprofen"
    ],
    "answer": "alcohol use with ibuprofen",
    "rationale": "High-risk interactions with ibuprofen can cause preventable harm; alcohol use is concerning because it can increases adverse effects.",
    "choice_rationales": {
      "alcohol use with ibuprofen": "Correct—alcohol use can increases adverse effects when combined with ibuprofen.",
      "saline nasal spray with ibuprofen": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "calcium carbonate with ibuprofen": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "acetaminophen (standard dosing) with ibuprofen": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option."
    },
    "case": {
      "tabs": {
        "case_study": "NSAID (ibuprofen): scenario involves acute musculoskeletal pain.",
        "vitals": "epigastric burning, HR 102, BP 128/78",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0007",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with metformin? Select all that apply.",
    "choices": [
      "Herbal supplement (St. John's wort)",
      "Opioid use while sedated",
      "Probiotic yogurt",
      "Another QT-prolonging medication",
      "Saline eye drops",
      "Topical moisturizer"
    ],
    "answer": [
      "Herbal supplement (St. John's wort)",
      "Opioid use while sedated",
      "Another QT-prolonging medication"
    ],
    "rationale": "For metformin, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Herbal supplement (St. John's wort)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "Topical moisturizer": "Incorrect—minimal interaction risk."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0008",
    "bank": "Pharmacology",
    "topic": "Pharmacology - TB therapy",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering isoniazid requires immediate action?",
    "choices": [
      "peripheral neuropathy",
      "mild headache that resolves with rest",
      "transient nausea",
      "sleepiness after taking the dose"
    ],
    "answer": "peripheral neuropathy",
    "rationale": "High-risk adverse reactions to isoniazid include hepatotoxicity, peripheral neuropathy. The nurse must respond to peripheral neuropathy immediately to prevent deterioration.",
    "choice_rationales": {
      "peripheral neuropathy": "Correct—peripheral neuropathy is a serious adverse effect associated with isoniazid and can progress rapidly if unaddressed.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "TB therapy (isoniazid): scenario involves latent TB infection.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "AST/ALT elevated; reports numbness/tingling",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0009",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving oxytocin?",
    "choices": [
      "I&O",
      "urine ketones",
      "temperature",
      "pupil size"
    ],
    "answer": "I&O",
    "rationale": "The key monitoring for oxytocin includes uterine tachysystole, FHR, I&O; in this case, I&O is the most safety-critical.",
    "choice_rationales": {
      "I&O": "Correct—monitoring I&O detects early complications of oxytocin and guides safety/therapeutic response.",
      "urine ketones": "Less relevant—urine ketones is not the priority parameter for oxytocin safety/efficacy.",
      "temperature": "Less relevant—temperature is not the priority parameter for oxytocin safety/efficacy.",
      "pupil size": "Less relevant—pupil size is not the priority parameter for oxytocin safety/efficacy."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "uterine contractions q1 min, FHR late decels",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0010",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Anti-emetic",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving ondansetron?",
    "choices": [
      "ECG if risk",
      "urine ketones",
      "bowel sounds",
      "pupil size"
    ],
    "answer": "ECG if risk",
    "rationale": "The key monitoring for ondansetron includes ECG if risk; in this case, ECG if risk is the most safety-critical.",
    "choice_rationales": {
      "ECG if risk": "Correct—monitoring ECG if risk detects early complications of ondansetron and guides safety/therapeutic response.",
      "urine ketones": "Less relevant—urine ketones is not the priority parameter for ondansetron safety/efficacy.",
      "bowel sounds": "Less relevant—bowel sounds is not the priority parameter for ondansetron safety/efficacy.",
      "pupil size": "Less relevant—pupil size is not the priority parameter for ondansetron safety/efficacy."
    },
    "case": {
      "tabs": {
        "case_study": "Anti-emetic (ondansetron): scenario involves postop nausea.",
        "vitals": "black tarry stools, HR 112, BP 96/58",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0011",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Magnesium sulfate",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of magnesium sulfate?",
    "choices": [
      "report warmth/flushing; notify for decreased urine output",
      "I will stop the medication as soon as I feel better.",
      "If I miss a dose, I will double the next dose.",
      "Herbal supplements are always safe with prescriptions."
    ],
    "answer": "report warmth/flushing; notify for decreased urine output",
    "rationale": "Key teaching for magnesium sulfate includes: report warmth/flushing; notify for decreased urine output. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "report warmth/flushing; notify for decreased urine output": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Magnesium sulfate (magnesium sulfate): scenario involves seizure prophylaxis in severe preeclampsia.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "Mg level 7.8 mg/dL; UO 20 mL/hr",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start magnesium sulfate per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0012",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Insulin (rapid-acting)",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting insulin lispro? Select all that apply.",
    "choices": [
      "rotate injection sites",
      "Stop the medication when symptoms improve",
      "Use teach-back to confirm understanding of dosing schedule",
      "Share prescription medications with family members if they have similar symptoms",
      "Store all medications in the bathroom medicine cabinet",
      "give with meals; onset minutes"
    ],
    "answer": [
      "rotate injection sites",
      "Use teach-back to confirm understanding of dosing schedule",
      "give with meals; onset minutes"
    ],
    "rationale": "Teaching for insulin lispro must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: give with meals; onset minutes, rotate injection sites.",
    "choice_rationales": {
      "rotate injection sites": "Correct—supports safe self-management and reduces risk.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "give with meals; onset minutes": "Correct—supports safe self-management and reduces risk."
    },
    "case": {
      "tabs": {
        "case_study": "Insulin (rapid-acting) (insulin lispro): scenario involves postprandial hyperglycemia.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0013",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Thyroid hormone",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting levothyroxine? Select all that apply.",
    "choices": [
      "Share prescription medications with family members if they have similar symptoms",
      "separate from calcium/iron",
      "Store all medications in the bathroom medicine cabinet",
      "take on empty stomach AM",
      "Keep an updated medication list and share it at every visit",
      "Stop the medication when symptoms improve"
    ],
    "answer": [
      "separate from calcium/iron",
      "take on empty stomach AM",
      "Keep an updated medication list and share it at every visit"
    ],
    "rationale": "Teaching for levothyroxine must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: take on empty stomach AM, separate from calcium/iron.",
    "choice_rationales": {
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "separate from calcium/iron": "Correct—supports safe self-management and reduces risk.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "take on empty stomach AM": "Correct—supports safe self-management and reduces risk.",
      "Keep an updated medication list and share it at every visit": "Correct—supports safe self-management and reduces risk.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Thyroid hormone (levothyroxine): scenario involves hypothyroidism.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0014",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Insulin (rapid-acting)",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold insulin lispro and notify the provider? Select all that apply.",
    "choices": [
      "Reports mild nausea",
      "Afebrile temperature 36.8°C (98.2°F)",
      "hypoglycemia",
      "Asks to take medication with orange juice",
      "BP 138/84 without symptoms",
      "Pain 4/10 relieved with repositioning"
    ],
    "answer": [
      "hypoglycemia"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for insulin lispro plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "hypoglycemia": "Correct—requires holding due to safety risk/contraindication.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Insulin (rapid-acting) (insulin lispro): scenario involves postprandial hyperglycemia.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0015",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Calcium channel blocker (dihydropyridine)",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering amlodipine requires immediate action?",
    "choices": [
      "sleepiness after taking the dose",
      "peripheral edema",
      "mild headache that resolves with rest",
      "dry mouth"
    ],
    "answer": "peripheral edema",
    "rationale": "High-risk adverse reactions to amlodipine include peripheral edema, headache, flushing. The nurse must respond to peripheral edema immediately to prevent deterioration.",
    "choice_rationales": {
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "peripheral edema": "Correct—peripheral edema is a serious adverse effect associated with amlodipine and can progress rapidly if unaddressed.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Calcium channel blocker (dihydropyridine) (amlodipine): scenario involves hypertension.",
        "vitals": "HR 46, BP 92/58, RR 16, SpO2 95% RA",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0016",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Direct oral anticoagulant",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold apixaban and notify the provider? Select all that apply.",
    "choices": [
      "active bleeding",
      "Pain 4/10 relieved with repositioning",
      "Asks to take medication with orange juice",
      "severe hepatic disease (varies)",
      "BP 138/84 without symptoms",
      "Afebrile temperature 36.8°C (98.2°F)"
    ],
    "answer": [
      "active bleeding",
      "severe hepatic disease (varies)"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for apixaban plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "active bleeding": "Correct—requires holding due to safety risk/contraindication.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "severe hepatic disease (varies)": "Correct—requires holding due to safety risk/contraindication.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Direct oral anticoagulant (apixaban): scenario involves DVT/PE prevention.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0017",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Beta blocker",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of metoprolol?",
    "choices": [
      "Herbal supplements are always safe with prescriptions.",
      "I will stop the medication as soon as I feel better.",
      "I can take this medication with alcohol to help me sleep.",
      "check pulse; hold/notify provider if below parameters"
    ],
    "answer": "check pulse; hold/notify provider if below parameters",
    "rationale": "Key teaching for metoprolol includes: check pulse; hold/notify provider if below parameters, do not stop abruptly. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "check pulse; hold/notify provider if below parameters": "Correct—this statement reflects safe, accurate self-management for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "Beta blocker (metoprolol): scenario involves rate control in atrial fibrillation.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0018",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the metformin is achieving the intended therapeutic effect?",
    "choices": [
      "new onset dizziness when standing",
      "symptom improvement with stable vital signs and target lab trends",
      "no symptom change after several doses",
      "development of rash and wheeze"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (type 2 diabetes). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0019",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SSRI",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the sertraline order before administering?",
    "choices": [
      "last bowel movement yesterday",
      "concurrent MAOI",
      "controlled asthma with no symptoms today",
      "BP 138/82 with no symptoms"
    ],
    "answer": "concurrent MAOI",
    "rationale": "sertraline should be questioned when concurrent MAOI is present because it can precipitate severe adverse outcomes (e.g., GI upset, sexual dysfunction).",
    "choice_rationales": {
      "last bowel movement yesterday": "Not the best—last bowel movement yesterday does not directly contraindicate sertraline in this scenario.",
      "concurrent MAOI": "Correct—concurrent MAOI is a contraindication/major caution for sertraline and increases risk of serious harm.",
      "controlled asthma with no symptoms today": "Not the best—controlled asthma with no symptoms today does not directly contraindicate sertraline in this scenario.",
      "BP 138/82 with no symptoms": "Not the best—BP 138/82 with no symptoms does not directly contraindicate sertraline in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "SSRI (sertraline): scenario involves major depressive disorder.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0020",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Immunization",
    "system": "Community/Public Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving influenza vaccine. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Give the next dose early to overcome the reaction",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy",
      "Send the client home because reactions usually resolve without treatment",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Avoid documenting to prevent alarming the client"
    ],
    "answer": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Give the next dose early to overcome the reaction": "Incorrect—unsafe and does not manage the reaction.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Send the client home because reactions usually resolve without treatment": "Incorrect—unsafe and does not manage the reaction.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction."
    },
    "case": {
      "tabs": {
        "case_study": "Immunization (influenza vaccine): scenario involves seasonal prevention.",
        "vitals": "afebrile, HR 84, BP 124/78",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start influenza vaccine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0021",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antifungal",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold fluconazole and notify the provider? Select all that apply.",
    "choices": [
      "Pain 4/10 relieved with repositioning",
      "Afebrile temperature 36.8°C (98.2°F)",
      "Asks to take medication with orange juice",
      "QT prolongation (caution)",
      "BP 138/84 without symptoms",
      "Reports mild nausea"
    ],
    "answer": [
      "QT prolongation (caution)"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for fluconazole plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "QT prolongation (caution)": "Correct—requires holding due to safety risk/contraindication.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Antifungal (fluconazole): scenario involves vaginal candidiasis.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0022",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Opioid analgesic",
    "system": "Perioperative/Critical Care",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering morphine, which findings should the nurse monitor closely for potential complications? Select all that apply.",
    "choices": [
      "dry skin in winter",
      "nausea",
      "mild hunger",
      "constipation",
      "hypotension",
      "mild thirst"
    ],
    "answer": [
      "nausea",
      "constipation",
      "hypotension"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of morphine: respiratory depression, constipation, hypotension.",
    "choice_rationales": {
      "dry skin in winter": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "nausea": "Correct—known complication/adverse effect requiring surveillance.",
      "mild hunger": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "constipation": "Correct—known complication/adverse effect requiring surveillance.",
      "hypotension": "Correct—known complication/adverse effect requiring surveillance.",
      "mild thirst": "Incorrect—non-specific, not a priority adverse effect for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "Opioid analgesic (morphine): scenario involves severe postoperative pain.",
        "vitals": "pain 9/10, HR 120, BP 152/88",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0023",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Calcium channel blocker (dihydropyridine)",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with amlodipine?",
    "choices": [
      "saline nasal spray with amlodipine",
      "multivitamin with amlodipine",
      "acetaminophen (standard dosing) with amlodipine",
      "OTC NSAIDs with amlodipine"
    ],
    "answer": "OTC NSAIDs with amlodipine",
    "rationale": "High-risk interactions with amlodipine can cause preventable harm; OTC NSAIDs is concerning because it can increases bleeding/GI risk.",
    "choice_rationales": {
      "saline nasal spray with amlodipine": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "multivitamin with amlodipine": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "acetaminophen (standard dosing) with amlodipine": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "OTC NSAIDs with amlodipine": "Correct—OTC NSAIDs can increases bleeding/GI risk when combined with amlodipine."
    },
    "case": {
      "tabs": {
        "case_study": "Calcium channel blocker (dihydropyridine) (amlodipine): scenario involves hypertension.",
        "vitals": "HR 46, BP 92/58, RR 16, SpO2 95% RA",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start amlodipine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0024",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Beta blocker",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, metoprolol is prescribed at 5 mg/kg/dose. The child weighs 44 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "80.0 mg",
      "120.0 mg",
      "105.0 mg",
      "100.0 mg"
    ],
    "answer": "100.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "80.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "105.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 44 lb.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start metoprolol per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0025",
    "bank": "Pharmacology",
    "topic": "Pharmacology - NSAID",
    "system": "Musculoskeletal",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering ibuprofen, which findings should the nurse monitor closely for potential complications? Select all that apply.",
    "choices": [
      "GI ulcer/bleed",
      "increased appetite after meal",
      "mild thirst",
      "mild hunger",
      "renal injury",
      "increased BP"
    ],
    "answer": [
      "GI ulcer/bleed",
      "renal injury",
      "increased BP"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of ibuprofen: GI ulcer/bleed, renal injury, increased BP.",
    "choice_rationales": {
      "GI ulcer/bleed": "Correct—known complication/adverse effect requiring surveillance.",
      "increased appetite after meal": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "mild thirst": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "mild hunger": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "renal injury": "Correct—known complication/adverse effect requiring surveillance.",
      "increased BP": "Correct—known complication/adverse effect requiring surveillance."
    },
    "case": {
      "tabs": {
        "case_study": "NSAID (ibuprofen): scenario involves acute musculoskeletal pain.",
        "vitals": "pain 7/10, HR 96, BP 136/82",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start ibuprofen per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0026",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antiepileptic",
    "system": "Neurologic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold phenytoin and notify the provider? Select all that apply.",
    "choices": [
      "Pain 4/10 relieved with repositioning",
      "sinus bradycardia/SA block (IV)",
      "Afebrile temperature 36.8°C (98.2°F)",
      "BP 138/84 without symptoms",
      "Asks to take medication with orange juice",
      "Reports mild nausea"
    ],
    "answer": [
      "sinus bradycardia/SA block (IV)"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for phenytoin plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "sinus bradycardia/SA block (IV)": "Correct—requires holding due to safety risk/contraindication.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Antiepileptic (phenytoin): scenario involves seizure prevention.",
        "vitals": "post-ictal, HR 102, BP 138/84",
        "labs": "phenytoin level 24 mcg/mL; nystagmus noted",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0027",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with metformin? Select all that apply. (Select the best response.)",
    "choices": [
      "Humidifier use",
      "Another QT-prolonging medication",
      "Probiotic yogurt",
      "Topical moisturizer",
      "Herbal supplement (St. John's wort)",
      "Opioid use while sedated"
    ],
    "answer": [
      "Another QT-prolonging medication",
      "Herbal supplement (St. John's wort)",
      "Opioid use while sedated"
    ],
    "rationale": "For metformin, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Herbal supplement (St. John's wort)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start metformin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0028",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, metformin is prescribed at 15 mg/kg/dose. The child weighs 55 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "450.0 mg",
      "375.0 mg",
      "300.0 mg",
      "380.0 mg"
    ],
    "answer": "375.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "450.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "375.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "300.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "380.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 55 lb.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0029",
    "bank": "Pharmacology",
    "topic": "Pharmacology - TB therapy",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with isoniazid?",
    "choices": [
      "multivitamin with isoniazid",
      "acetaminophen excess with isoniazid",
      "fiber supplement with isoniazid",
      "acetaminophen (standard dosing) with isoniazid"
    ],
    "answer": "acetaminophen excess with isoniazid",
    "rationale": "High-risk interactions with isoniazid can cause preventable harm; acetaminophen excess is concerning because it can ↑hepatotoxicity.",
    "choice_rationales": {
      "multivitamin with isoniazid": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "acetaminophen excess with isoniazid": "Correct—acetaminophen excess can ↑hepatotoxicity when combined with isoniazid.",
      "fiber supplement with isoniazid": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "acetaminophen (standard dosing) with isoniazid": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option."
    },
    "case": {
      "tabs": {
        "case_study": "TB therapy (isoniazid): scenario involves latent TB infection.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "AST/ALT elevated; reports numbness/tingling",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start isoniazid per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0030",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving metformin. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Avoid documenting to prevent alarming the client",
      "Send the client home because reactions usually resolve without treatment",
      "Offer only ice chips and reassess in 6 hours",
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability"
    ],
    "answer": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Send the client home because reactions usually resolve without treatment": "Incorrect—unsafe and does not manage the reaction.",
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0031",
    "bank": "Pharmacology",
    "topic": "Pharmacology - PPI",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, pantoprazole is prescribed at 15 mg/kg/dose. The child weighs 44 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "305.0 mg",
      "300.0 mg",
      "240.0 mg",
      "360.0 mg"
    ],
    "answer": "300.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "305.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "300.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "240.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "360.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 44 lb.",
        "vitals": "black tarry stools, HR 112, BP 96/58",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0032",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antiepileptic",
    "system": "Neurologic",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with phenytoin?",
    "choices": [
      "acetaminophen (standard dosing) with phenytoin",
      "fiber supplement with phenytoin",
      "calcium carbonate with phenytoin",
      "oral contraceptive with phenytoin"
    ],
    "answer": "oral contraceptive with phenytoin",
    "rationale": "High-risk interactions with phenytoin can cause preventable harm; oral contraceptive is concerning because it can ↓contraceptive effectiveness.",
    "choice_rationales": {
      "acetaminophen (standard dosing) with phenytoin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "fiber supplement with phenytoin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "calcium carbonate with phenytoin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "oral contraceptive with phenytoin": "Correct—oral contraceptive can ↓contraceptive effectiveness when combined with phenytoin."
    },
    "case": {
      "tabs": {
        "case_study": "Antiepileptic (phenytoin): scenario involves seizure prevention.",
        "vitals": "post-ictal, HR 102, BP 138/84",
        "labs": "phenytoin level 24 mcg/mL; nystagmus noted",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0033",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (macrolide)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of azithromycin?",
    "choices": [
      "I will stop the medication as soon as I feel better.",
      "complete therapy",
      "Herbal supplements are always safe with prescriptions.",
      "I can take this medication with alcohol to help me sleep."
    ],
    "answer": "complete therapy",
    "rationale": "Key teaching for azithromycin includes: report palpitations/syncope, complete therapy. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "complete therapy": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (macrolide) (azithromycin): scenario involves community-acquired pneumonia.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start azithromycin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0034",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Heparin (unfractionated)",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting heparin? Select all that apply.",
    "choices": [
      "Store all medications in the bathroom medicine cabinet",
      "Use teach-back to confirm understanding of dosing schedule",
      "use soft toothbrush/electric razor",
      "report black stools, bleeding gums",
      "Share prescription medications with family members if they have similar symptoms",
      "Double the next dose if one is missed"
    ],
    "answer": [
      "Use teach-back to confirm understanding of dosing schedule",
      "use soft toothbrush/electric razor",
      "report black stools, bleeding gums"
    ],
    "rationale": "Teaching for heparin must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: use soft toothbrush/electric razor, report black stools, bleeding gums.",
    "choice_rationales": {
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "use soft toothbrush/electric razor": "Correct—supports safe self-management and reduces risk.",
      "report black stools, bleeding gums": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Heparin (unfractionated) (heparin): scenario involves DVT treatment.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0035",
    "bank": "Pharmacology",
    "topic": "Pharmacology - TB therapy",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving isoniazid?",
    "choices": [
      "bowel sounds",
      "neuropathy",
      "pupil size",
      "temperature"
    ],
    "answer": "neuropathy",
    "rationale": "The key monitoring for isoniazid includes LFTs, neuropathy; in this case, neuropathy is the most safety-critical.",
    "choice_rationales": {
      "bowel sounds": "Less relevant—bowel sounds is not the priority parameter for isoniazid safety/efficacy.",
      "neuropathy": "Correct—monitoring neuropathy detects early complications of isoniazid and guides safety/therapeutic response.",
      "pupil size": "Less relevant—pupil size is not the priority parameter for isoniazid safety/efficacy.",
      "temperature": "Less relevant—temperature is not the priority parameter for isoniazid safety/efficacy."
    },
    "case": {
      "tabs": {
        "case_study": "TB therapy (isoniazid): scenario involves latent TB infection.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "AST/ALT elevated; reports numbness/tingling",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start isoniazid per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0036",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering oxytocin requires immediate action?",
    "choices": [
      "sleepiness after taking the dose",
      "uterine tachysystole",
      "transient nausea",
      "dry mouth"
    ],
    "answer": "uterine tachysystole",
    "rationale": "High-risk adverse reactions to oxytocin include uterine tachysystole, water intoxication (rare). The nurse must respond to uterine tachysystole immediately to prevent deterioration.",
    "choice_rationales": {
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "uterine tachysystole": "Correct—uterine tachysystole is a serious adverse effect associated with oxytocin and can progress rapidly if unaddressed.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "uterine contractions q1 min, FHR late decels",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0037",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Anti-emetic",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the ondansetron is achieving the intended therapeutic effect?",
    "choices": [
      "symptom improvement with stable vital signs and target lab trends",
      "development of rash and wheeze",
      "new onset dizziness when standing",
      "worsening lab abnormalities"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (postop nausea). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Anti-emetic (ondansetron): scenario involves postop nausea.",
        "vitals": "N/V, HR 98, BP 122/74, dry mucosa",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start ondansetron per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0038",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Heparin (unfractionated)",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold heparin and notify the provider? Select all that apply.",
    "choices": [
      "history of HIT",
      "BP 138/84 without symptoms",
      "active bleeding",
      "Pain 4/10 relieved with repositioning",
      "Afebrile temperature 36.8°C (98.2°F)",
      "Reports mild nausea"
    ],
    "answer": [
      "history of HIT",
      "active bleeding"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for heparin plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "history of HIT": "Correct—requires holding due to safety risk/contraindication.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "active bleeding": "Correct—requires holding due to safety risk/contraindication.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Heparin (unfractionated) (heparin): scenario involves DVT treatment.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start heparin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0039",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Magnesium sulfate",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the magnesium sulfate order before administering?",
    "choices": [
      "BP 138/82 with no symptoms",
      "headache rated 3/10",
      "myasthenia gravis",
      "history of seasonal allergies (pollen)"
    ],
    "answer": "myasthenia gravis",
    "rationale": "magnesium sulfate should be questioned when myasthenia gravis is present because it can precipitate severe adverse outcomes (e.g., respiratory depression, loss of DTRs).",
    "choice_rationales": {
      "BP 138/82 with no symptoms": "Not the best—BP 138/82 with no symptoms does not directly contraindicate magnesium sulfate in this scenario.",
      "headache rated 3/10": "Not the best—headache rated 3/10 does not directly contraindicate magnesium sulfate in this scenario.",
      "myasthenia gravis": "Correct—myasthenia gravis is a contraindication/major caution for magnesium sulfate and increases risk of serious harm.",
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate magnesium sulfate in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Magnesium sulfate (magnesium sulfate): scenario involves seizure prophylaxis in severe preeclampsia.",
        "vitals": "uterine contractions q1 min, FHR late decels",
        "labs": "Mg level 7.8 mg/dL; UO 20 mL/hr",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start magnesium sulfate per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0040",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the metformin order before administering?",
    "choices": [
      "acute metabolic acidosis",
      "last bowel movement yesterday",
      "history of seasonal allergies (pollen)",
      "controlled asthma with no symptoms today"
    ],
    "answer": "acute metabolic acidosis",
    "rationale": "metformin should be questioned when acute metabolic acidosis is present because it can precipitate severe adverse outcomes (e.g., GI upset, lactic acidosis (rare)).",
    "choice_rationales": {
      "acute metabolic acidosis": "Correct—acute metabolic acidosis is a contraindication/major caution for metformin and increases risk of serious harm.",
      "last bowel movement yesterday": "Not the best—last bowel movement yesterday does not directly contraindicate metformin in this scenario.",
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate metformin in this scenario.",
      "controlled asthma with no symptoms today": "Not the best—controlled asthma with no symptoms today does not directly contraindicate metformin in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0041",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antifungal",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the fluconazole order before administering?",
    "choices": [
      "QT prolongation (caution)",
      "headache rated 3/10",
      "mild nausea after breakfast",
      "history of seasonal allergies (pollen)"
    ],
    "answer": "QT prolongation (caution)",
    "rationale": "fluconazole should be questioned when QT prolongation (caution) is present because it can precipitate severe adverse outcomes (e.g., hepatotoxicity (rare), drug interactions (CYP)).",
    "choice_rationales": {
      "QT prolongation (caution)": "Correct—QT prolongation (caution) is a contraindication/major caution for fluconazole and increases risk of serious harm.",
      "headache rated 3/10": "Not the best—headache rated 3/10 does not directly contraindicate fluconazole in this scenario.",
      "mild nausea after breakfast": "Not the best—mild nausea after breakfast does not directly contraindicate fluconazole in this scenario.",
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate fluconazole in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Antifungal (fluconazole): scenario involves vaginal candidiasis.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0042",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Corticosteroid (systemic)",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering prednisone, which findings should the nurse monitor closely for potential complications? Select all that apply.",
    "choices": [
      "increased appetite after meal",
      "mood changes",
      "mild hunger",
      "mild thirst",
      "immunosuppression",
      "hyperglycemia"
    ],
    "answer": [
      "mood changes",
      "immunosuppression",
      "hyperglycemia"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of prednisone: hyperglycemia, immunosuppression, GI irritation.",
    "choice_rationales": {
      "increased appetite after meal": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "mood changes": "Correct—known complication/adverse effect requiring surveillance.",
      "mild hunger": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "mild thirst": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "immunosuppression": "Correct—known complication/adverse effect requiring surveillance.",
      "hyperglycemia": "Correct—known complication/adverse effect requiring surveillance."
    },
    "case": {
      "tabs": {
        "case_study": "Corticosteroid (systemic) (prednisone): scenario involves acute COPD exacerbation.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "BG 286 mg/dL; WBC 14.2K",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0043",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Direct oral anticoagulant",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with apixaban?",
    "choices": [
      "alcohol use with apixaban",
      "fiber supplement with apixaban",
      "multivitamin with apixaban",
      "saline nasal spray with apixaban"
    ],
    "answer": "alcohol use with apixaban",
    "rationale": "High-risk interactions with apixaban can cause preventable harm; alcohol use is concerning because it can increases adverse effects.",
    "choice_rationales": {
      "alcohol use with apixaban": "Correct—alcohol use can increases adverse effects when combined with apixaban.",
      "fiber supplement with apixaban": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "multivitamin with apixaban": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "saline nasal spray with apixaban": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option."
    },
    "case": {
      "tabs": {
        "case_study": "Direct oral anticoagulant (apixaban): scenario involves DVT/PE prevention.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0044",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Benzodiazepine",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving lorazepam?",
    "choices": [
      "skin turgor",
      "pupil size",
      "urine ketones",
      "sedation"
    ],
    "answer": "sedation",
    "rationale": "The key monitoring for lorazepam includes sedation, respirations; in this case, sedation is the most safety-critical.",
    "choice_rationales": {
      "skin turgor": "Less relevant—skin turgor is not the priority parameter for lorazepam safety/efficacy.",
      "pupil size": "Less relevant—pupil size is not the priority parameter for lorazepam safety/efficacy.",
      "urine ketones": "Less relevant—urine ketones is not the priority parameter for lorazepam safety/efficacy.",
      "sedation": "Correct—monitoring sedation detects early complications of lorazepam and guides safety/therapeutic response."
    },
    "case": {
      "tabs": {
        "case_study": "Benzodiazepine (lorazepam): scenario involves acute severe anxiety.",
        "vitals": "anxious, HR 126, BP 140/86, RR 22",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0045",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Beta blocker",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of metoprolol? (Select the best response.)",
    "choices": [
      "check pulse; hold/notify provider if below parameters",
      "If I miss a dose, I will double the next dose.",
      "I will stop the medication as soon as I feel better.",
      "Herbal supplements are always safe with prescriptions."
    ],
    "answer": "check pulse; hold/notify provider if below parameters",
    "rationale": "Key teaching for metoprolol includes: check pulse; hold/notify provider if below parameters, do not stop abruptly. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "check pulse; hold/notify provider if below parameters": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Beta blocker (metoprolol): scenario involves rate control in atrial fibrillation.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0046",
    "bank": "Pharmacology",
    "topic": "Pharmacology - ACE inhibitor",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the lisinopril is achieving the intended therapeutic effect?",
    "choices": [
      "new onset dizziness when standing",
      "development of rash and wheeze",
      "no symptom change after several doses",
      "symptom improvement with stable vital signs and target lab trends"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (hypertension with diabetes). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication."
    },
    "case": {
      "tabs": {
        "case_study": "ACE inhibitor (lisinopril): scenario involves hypertension with diabetes.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0047",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Benzodiazepine",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the lorazepam is achieving the intended therapeutic effect?",
    "choices": [
      "symptom improvement with stable vital signs and target lab trends",
      "new onset dizziness when standing",
      "worsening lab abnormalities",
      "development of rash and wheeze"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (acute severe anxiety). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Benzodiazepine (lorazepam): scenario involves acute severe anxiety.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0048",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Insulin (rapid-acting)",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, sliding-scale insulin lispro is ordered: 151–200 = 2 units, 201–250 = 4 units, 251–300 = 6 units, 301–350 = 8 units. What dose should the nurse administer?",
    "choices": [
      "8 units",
      "4 units",
      "2 units",
      "6 units"
    ],
    "answer": "2 units",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "8 units": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "4 units": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "2 units": "Correct—calculation and/or unit conversion matches the order.",
      "6 units": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Insulin (rapid-acting) (insulin lispro): scenario involves postprandial hyperglycemia.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "Point-of-care glucose: 178 mg/dL",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0049",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SABA bronchodilator",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering albuterol requires immediate action?",
    "choices": [
      "sleepiness after taking the dose",
      "mild headache that resolves with rest",
      "dry mouth",
      "tachycardia"
    ],
    "answer": "tachycardia",
    "rationale": "High-risk adverse reactions to albuterol include tachycardia, tremor, hypokalemia (high dose). The nurse must respond to tachycardia immediately to prevent deterioration.",
    "choice_rationales": {
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "tachycardia": "Correct—tachycardia is a serious adverse effect associated with albuterol and can progress rapidly if unaddressed."
    },
    "case": {
      "tabs": {
        "case_study": "SABA bronchodilator (albuterol): scenario involves acute bronchospasm.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start albuterol per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0050",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Thyroid hormone",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the levothyroxine is achieving the intended therapeutic effect?",
    "choices": [
      "worsening lab abnormalities",
      "no symptom change after several doses",
      "TSH trending toward target and improved energy",
      "new onset dizziness when standing"
    ],
    "answer": "TSH trending toward target and improved energy",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (hypothyroidism). The best indicator is: TSH trending toward target and improved energy.",
    "choice_rationales": {
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "TSH trending toward target and improved energy": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Thyroid hormone (levothyroxine): scenario involves hypothyroidism.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0051",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (vancomycin)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of vancomycin?",
    "choices": [
      "report ringing in ears",
      "I can take this medication with alcohol to help me sleep.",
      "Herbal supplements are always safe with prescriptions.",
      "If I miss a dose, I will double the next dose."
    ],
    "answer": "report ringing in ears",
    "rationale": "Key teaching for vancomycin includes: infuse slowly, report ringing in ears. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "report ringing in ears": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (vancomycin) (vancomycin): scenario involves MRSA bacteremia.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "Cr 1.6 (up from 1.0); vanc trough 24 mcg/mL",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0052",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Corticosteroid (systemic)",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with prednisone? Select all that apply.",
    "choices": [
      "Saline eye drops",
      "Alcohol use (2–3 drinks nightly)",
      "Topical moisturizer",
      "Warm compresses",
      "Opioid use while sedated",
      "Potassium-containing salt substitute"
    ],
    "answer": [
      "Alcohol use (2–3 drinks nightly)",
      "Opioid use while sedated",
      "Potassium-containing salt substitute"
    ],
    "rationale": "For prednisone, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Warm compresses": "Incorrect—minimal interaction risk.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Potassium-containing salt substitute": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Corticosteroid (systemic) (prednisone): scenario involves acute COPD exacerbation.",
        "vitals": "RR 28, SpO2 88% RA, HR 110, BP 142/86",
        "labs": "BG 286 mg/dL; WBC 14.2K",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start prednisone per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0053",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Thyroid hormone",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, levothyroxine is prescribed at 15 mg/kg/dose. The child weighs 33 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "270.0 mg",
      "230.0 mg",
      "180.0 mg",
      "225.0 mg"
    ],
    "answer": "225.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "270.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "230.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "180.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "225.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 33 lb.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0054",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SSRI",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting sertraline? Select all that apply.",
    "choices": [
      "Keep an updated medication list and share it at every visit",
      "seek help for worsening thoughts",
      "Stop the medication when symptoms improve",
      "Store all medications in the bathroom medicine cabinet",
      "Double the next dose if one is missed",
      "do not stop abruptly"
    ],
    "answer": [
      "Keep an updated medication list and share it at every visit",
      "seek help for worsening thoughts",
      "do not stop abruptly"
    ],
    "rationale": "Teaching for sertraline must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: takes weeks to work, do not stop abruptly.",
    "choice_rationales": {
      "Keep an updated medication list and share it at every visit": "Correct—supports safe self-management and reduces risk.",
      "seek help for worsening thoughts": "Correct—supports safe self-management and reduces risk.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "do not stop abruptly": "Correct—supports safe self-management and reduces risk."
    },
    "case": {
      "tabs": {
        "case_study": "SSRI (sertraline): scenario involves major depressive disorder.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start sertraline per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0055",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, oxytocin is prescribed at 15 mg/kg/dose. The child weighs 55 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "300.0 mg",
      "375.0 mg",
      "380.0 mg",
      "450.0 mg"
    ],
    "answer": "375.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "300.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "375.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "380.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "450.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 55 lb.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0056",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (macrolide)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, azithromycin is prescribed at 15 mg/kg/dose. The child weighs 22 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "180.0 mg",
      "155.0 mg",
      "150.0 mg",
      "120.0 mg"
    ],
    "answer": "150.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "180.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "155.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "150.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 22 lb.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0057",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with metformin?",
    "choices": [
      "multivitamin with metformin",
      "calcium carbonate with metformin",
      "fiber supplement with metformin",
      "iodinated contrast study with metformin"
    ],
    "answer": "iodinated contrast study with metformin",
    "rationale": "High-risk interactions with metformin can cause preventable harm; iodinated contrast study is concerning because it can ↑lactic acidosis risk if renal injury.",
    "choice_rationales": {
      "multivitamin with metformin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "calcium carbonate with metformin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "fiber supplement with metformin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "iodinated contrast study with metformin": "Correct—iodinated contrast study can ↑lactic acidosis risk if renal injury when combined with metformin."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0058",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Sulfonylurea",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting glipizide? Select all that apply.",
    "choices": [
      "recognize hypoglycemia signs",
      "eat consistent meals",
      "Double the next dose if one is missed",
      "Stop the medication when symptoms improve",
      "Use teach-back to confirm understanding of dosing schedule",
      "Share prescription medications with family members if they have similar symptoms"
    ],
    "answer": [
      "recognize hypoglycemia signs",
      "eat consistent meals",
      "Use teach-back to confirm understanding of dosing schedule"
    ],
    "rationale": "Teaching for glipizide must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: eat consistent meals, recognize hypoglycemia signs.",
    "choice_rationales": {
      "recognize hypoglycemia signs": "Correct—supports safe self-management and reduces risk.",
      "eat consistent meals": "Correct—supports safe self-management and reduces risk.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Sulfonylurea (glipizide): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0059",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Beta blocker",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with metoprolol? Select all that apply.",
    "choices": [
      "Probiotic yogurt",
      "Another QT-prolonging medication",
      "Opioid use while sedated",
      "Saline eye drops",
      "Warm compresses",
      "Alcohol use (2–3 drinks nightly)"
    ],
    "answer": [
      "Another QT-prolonging medication",
      "Opioid use while sedated",
      "Alcohol use (2–3 drinks nightly)"
    ],
    "rationale": "For metoprolol, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "Warm compresses": "Incorrect—minimal interaction risk.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Beta blocker (metoprolol): scenario involves rate control in atrial fibrillation.",
        "vitals": "HR 46, BP 92/58, RR 16, SpO2 95% RA",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start metoprolol per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0060",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Benzodiazepine",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving lorazepam. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Avoid documenting to prevent alarming the client",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Document the reaction and update the allergy list per policy",
      "Prepare and administer reversal agent per order/protocol (e.g., naloxone) and support ventilation",
      "Give the next dose early to overcome the reaction",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing"
    ],
    "answer": [
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Document the reaction and update the allergy list per policy",
      "Prepare and administer reversal agent per order/protocol (e.g., naloxone) and support ventilation",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Prepare and administer reversal agent per order/protocol (e.g., naloxone) and support ventilation": "Correct—aligns with adverse reaction management and patient safety.",
      "Give the next dose early to overcome the reaction": "Incorrect—unsafe and does not manage the reaction.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety."
    },
    "case": {
      "tabs": {
        "case_study": "Benzodiazepine (lorazepam): scenario involves acute severe anxiety.",
        "vitals": "anxious, HR 126, BP 140/86, RR 22",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0061",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Opioid analgesic",
    "system": "Perioperative/Critical Care",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, morphine is prescribed at 10 mg/kg/dose. The child weighs 22 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "80.0 mg",
      "100.0 mg",
      "120.0 mg",
      "105.0 mg"
    ],
    "answer": "100.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "80.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "105.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 22 lb.",
        "vitals": "RR 8, SpO2 90% on 2L NC, HR 58, BP 86/48",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0062",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Corticosteroid (systemic)",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with prednisone?",
    "choices": [
      "fiber supplement with prednisone",
      "OTC NSAIDs with prednisone",
      "saline nasal spray with prednisone",
      "acetaminophen (standard dosing) with prednisone"
    ],
    "answer": "OTC NSAIDs with prednisone",
    "rationale": "High-risk interactions with prednisone can cause preventable harm; OTC NSAIDs is concerning because it can increases bleeding/GI risk.",
    "choice_rationales": {
      "fiber supplement with prednisone": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "OTC NSAIDs with prednisone": "Correct—OTC NSAIDs can increases bleeding/GI risk when combined with prednisone.",
      "saline nasal spray with prednisone": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "acetaminophen (standard dosing) with prednisone": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option."
    },
    "case": {
      "tabs": {
        "case_study": "Corticosteroid (systemic) (prednisone): scenario involves acute COPD exacerbation.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "BG 286 mg/dL; WBC 14.2K",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0063",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Corticosteroid (systemic)",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting prednisone? Select all that apply.",
    "choices": [
      "take with food",
      "Keep an updated medication list and share it at every visit",
      "do not stop abruptly after prolonged use",
      "Share prescription medications with family members if they have similar symptoms",
      "Double the next dose if one is missed",
      "Store all medications in the bathroom medicine cabinet"
    ],
    "answer": [
      "take with food",
      "Keep an updated medication list and share it at every visit",
      "do not stop abruptly after prolonged use"
    ],
    "rationale": "Teaching for prednisone must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: take with food, do not stop abruptly after prolonged use.",
    "choice_rationales": {
      "take with food": "Correct—supports safe self-management and reduces risk.",
      "Keep an updated medication list and share it at every visit": "Correct—supports safe self-management and reduces risk.",
      "do not stop abruptly after prolonged use": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Corticosteroid (systemic) (prednisone): scenario involves acute COPD exacerbation.",
        "vitals": "RR 28, SpO2 88% RA, HR 110, BP 142/86",
        "labs": "BG 286 mg/dL; WBC 14.2K",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0064",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, metformin is prescribed at 5 mg/kg/dose. The child weighs 22 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "50.0 mg",
      "40.0 mg",
      "55.0 mg",
      "60.0 mg"
    ],
    "answer": "50.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "50.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "40.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "55.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "60.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 22 lb.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0065",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Sulfonylurea",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the glipizide order?",
    "choices": [
      "Ask the family to decide whether the client wants the medication today",
      "Verify the order, allergies, and two patient identifiers before administration",
      "Skip patient education because the medication is routine",
      "Give the medication first and then check the client’s vitals"
    ],
    "answer": "Verify the order, allergies, and two patient identifiers before administration",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering glipizide.",
    "choice_rationales": {
      "Ask the family to decide whether the client wants the medication today": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Verify the order, allergies, and two patient identifiers before administration": "Correct—this action prevents a medication error and aligns with safe administration standards.",
      "Skip patient education because the medication is routine": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Give the medication first and then check the client’s vitals": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment."
    },
    "case": {
      "tabs": {
        "case_study": "Sulfonylurea (glipizide): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0066",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (vancomycin)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving vancomycin. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Offer only ice chips and reassess in 6 hours",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Give the next dose early to overcome the reaction",
      "Document the reaction and update the allergy list per policy",
      "Send the client home because reactions usually resolve without treatment"
    ],
    "answer": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Document the reaction and update the allergy list per policy"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Give the next dose early to overcome the reaction": "Incorrect—unsafe and does not manage the reaction.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Send the client home because reactions usually resolve without treatment": "Incorrect—unsafe and does not manage the reaction."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (vancomycin) (vancomycin): scenario involves MRSA bacteremia.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "Cr 1.6 (up from 1.0); vanc trough 24 mcg/mL",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start vancomycin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0067",
    "bank": "Pharmacology",
    "topic": "Pharmacology - PPI",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with pantoprazole? Select all that apply.",
    "choices": [
      "Another QT-prolonging medication",
      "Probiotic yogurt",
      "Alcohol use (2–3 drinks nightly)",
      "Warm compresses",
      "Opioid use while sedated",
      "Topical moisturizer"
    ],
    "answer": [
      "Another QT-prolonging medication",
      "Alcohol use (2–3 drinks nightly)",
      "Opioid use while sedated"
    ],
    "rationale": "For pantoprazole, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Warm compresses": "Incorrect—minimal interaction risk.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Topical moisturizer": "Incorrect—minimal interaction risk."
    },
    "case": {
      "tabs": {
        "case_study": "PPI (pantoprazole): scenario involves stress ulcer prophylaxis ICU.",
        "vitals": "black tarry stools, HR 112, BP 96/58",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0068",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Loop diuretic",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with furosemide? Select all that apply.",
    "choices": [
      "Probiotic yogurt",
      "Topical moisturizer",
      "Opioid use while sedated",
      "Herbal supplement (St. John's wort)",
      "Another QT-prolonging medication",
      "Saline eye drops"
    ],
    "answer": [
      "Opioid use while sedated",
      "Herbal supplement (St. John's wort)",
      "Another QT-prolonging medication"
    ],
    "rationale": "For furosemide, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Herbal supplement (St. John's wort)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Saline eye drops": "Incorrect—minimal interaction risk."
    },
    "case": {
      "tabs": {
        "case_study": "Loop diuretic (furosemide): scenario involves acute pulmonary edema.",
        "vitals": "HR 46, BP 92/58, RR 16, SpO2 95% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0069",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Opioid analgesic",
    "system": "Perioperative/Critical Care",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the morphine order before administering?",
    "choices": [
      "headache rated 3/10",
      "history of seasonal allergies (pollen)",
      "BP 138/82 with no symptoms",
      "respiratory depression"
    ],
    "answer": "respiratory depression",
    "rationale": "morphine should be questioned when respiratory depression is present because it can precipitate severe adverse outcomes (e.g., respiratory depression, constipation).",
    "choice_rationales": {
      "headache rated 3/10": "Not the best—headache rated 3/10 does not directly contraindicate morphine in this scenario.",
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate morphine in this scenario.",
      "BP 138/82 with no symptoms": "Not the best—BP 138/82 with no symptoms does not directly contraindicate morphine in this scenario.",
      "respiratory depression": "Correct—respiratory depression is a contraindication/major caution for morphine and increases risk of serious harm."
    },
    "case": {
      "tabs": {
        "case_study": "Opioid analgesic (morphine): scenario involves severe postoperative pain.",
        "vitals": "RR 8, SpO2 90% on 2L NC, HR 58, BP 86/48",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start morphine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0070",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Immunization",
    "system": "Community/Public Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with influenza vaccine? Select all that apply.",
    "choices": [
      "Potassium-containing salt substitute",
      "Opioid use while sedated",
      "Probiotic yogurt",
      "Saline eye drops",
      "OTC NSAIDs used daily",
      "Topical moisturizer"
    ],
    "answer": [
      "Potassium-containing salt substitute",
      "Opioid use while sedated",
      "OTC NSAIDs used daily"
    ],
    "rationale": "For influenza vaccine, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Potassium-containing salt substitute": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "OTC NSAIDs used daily": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Topical moisturizer": "Incorrect—minimal interaction risk."
    },
    "case": {
      "tabs": {
        "case_study": "Immunization (influenza vaccine): scenario involves seasonal prevention.",
        "vitals": "low-grade fever 37.8°C (100°F), HR 92",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0071",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (macrolide)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting azithromycin? Select all that apply.",
    "choices": [
      "Store all medications in the bathroom medicine cabinet",
      "Call the clinic before starting any OTC/herbal products",
      "complete therapy",
      "report palpitations/syncope",
      "Share prescription medications with family members if they have similar symptoms",
      "Stop the medication when symptoms improve"
    ],
    "answer": [
      "Call the clinic before starting any OTC/herbal products",
      "complete therapy",
      "report palpitations/syncope"
    ],
    "rationale": "Teaching for azithromycin must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: report palpitations/syncope, complete therapy.",
    "choice_rationales": {
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Call the clinic before starting any OTC/herbal products": "Correct—supports safe self-management and reduces risk.",
      "complete therapy": "Correct—supports safe self-management and reduces risk.",
      "report palpitations/syncope": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (macrolide) (azithromycin): scenario involves community-acquired pneumonia.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0072",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Beta blocker",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the metoprolol order?",
    "choices": [
      "Ask the family to decide whether the client wants the medication today",
      "Skip patient education because the medication is routine",
      "Give the medication first and then check the client’s vitals",
      "Assess the parameter that determines whether to hold the medication (per protocol) before giving"
    ],
    "answer": "Assess the parameter that determines whether to hold the medication (per protocol) before giving",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering metoprolol.",
    "choice_rationales": {
      "Ask the family to decide whether the client wants the medication today": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Skip patient education because the medication is routine": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Give the medication first and then check the client’s vitals": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Assess the parameter that determines whether to hold the medication (per protocol) before giving": "Correct—this action prevents a medication error and aligns with safe administration standards."
    },
    "case": {
      "tabs": {
        "case_study": "Beta blocker (metoprolol): scenario involves rate control in atrial fibrillation.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start metoprolol per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0073",
    "bank": "Pharmacology",
    "topic": "Pharmacology - TB therapy",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, isoniazid is prescribed at 15 mg/kg/dose. The child weighs 44 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "240.0 mg",
      "360.0 mg",
      "300.0 mg",
      "305.0 mg"
    ],
    "answer": "300.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "240.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "360.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "300.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "305.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 44 lb.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "AST/ALT elevated; reports numbness/tingling",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0074",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Thyroid hormone",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting levothyroxine? Select all that apply. (Select the best response.)",
    "choices": [
      "Store all medications in the bathroom medicine cabinet",
      "Use teach-back to confirm understanding of dosing schedule",
      "Share prescription medications with family members if they have similar symptoms",
      "take on empty stomach AM",
      "separate from calcium/iron",
      "Double the next dose if one is missed"
    ],
    "answer": [
      "Use teach-back to confirm understanding of dosing schedule",
      "take on empty stomach AM",
      "separate from calcium/iron"
    ],
    "rationale": "Teaching for levothyroxine must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: take on empty stomach AM, separate from calcium/iron.",
    "choice_rationales": {
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "take on empty stomach AM": "Correct—supports safe self-management and reduces risk.",
      "separate from calcium/iron": "Correct—supports safe self-management and reduces risk.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Thyroid hormone (levothyroxine): scenario involves hypothyroidism.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0075",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with metformin? Select all that apply. (Select the best response.)",
    "choices": [
      "Humidifier use",
      "Saline eye drops",
      "Probiotic yogurt",
      "Alcohol use (2–3 drinks nightly)",
      "Herbal supplement (St. John's wort)",
      "Opioid use while sedated"
    ],
    "answer": [
      "Alcohol use (2–3 drinks nightly)",
      "Herbal supplement (St. John's wort)",
      "Opioid use while sedated"
    ],
    "rationale": "For metformin, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Herbal supplement (St. John's wort)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0076",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Sulfonylurea",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the glipizide order before administering?",
    "choices": [
      "controlled asthma with no symptoms today",
      "DKA",
      "last bowel movement yesterday",
      "history of seasonal allergies (pollen)"
    ],
    "answer": "DKA",
    "rationale": "glipizide should be questioned when DKA is present because it can precipitate severe adverse outcomes (e.g., hypoglycemia, weight gain).",
    "choice_rationales": {
      "controlled asthma with no symptoms today": "Not the best—controlled asthma with no symptoms today does not directly contraindicate glipizide in this scenario.",
      "DKA": "Correct—DKA is a contraindication/major caution for glipizide and increases risk of serious harm.",
      "last bowel movement yesterday": "Not the best—last bowel movement yesterday does not directly contraindicate glipizide in this scenario.",
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate glipizide in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Sulfonylurea (glipizide): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0077",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Opioid analgesic",
    "system": "Perioperative/Critical Care",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, morphine is prescribed at 5 mg/kg/dose. The child weighs 44 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "120.0 mg",
      "105.0 mg",
      "80.0 mg",
      "100.0 mg"
    ],
    "answer": "100.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "105.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "80.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 44 lb.",
        "vitals": "RR 8, SpO2 90% on 2L NC, HR 58, BP 86/48",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0078",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Anti-emetic",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the ondansetron order?",
    "choices": [
      "Document the dose as given before administering to save time",
      "Ask the family to decide whether the client wants the medication today",
      "Clarify unclear dosing units with the prescriber before preparing the medication",
      "Give the medication first and then check the client’s vitals"
    ],
    "answer": "Clarify unclear dosing units with the prescriber before preparing the medication",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering ondansetron.",
    "choice_rationales": {
      "Document the dose as given before administering to save time": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Ask the family to decide whether the client wants the medication today": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Clarify unclear dosing units with the prescriber before preparing the medication": "Correct—this action prevents a medication error and aligns with safe administration standards.",
      "Give the medication first and then check the client’s vitals": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment."
    },
    "case": {
      "tabs": {
        "case_study": "Anti-emetic (ondansetron): scenario involves postop nausea.",
        "vitals": "black tarry stools, HR 112, BP 96/58",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start ondansetron per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0079",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Magnesium sulfate",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering magnesium sulfate requires immediate action?",
    "choices": [
      "loss of DTRs",
      "mild headache that resolves with rest",
      "dry mouth",
      "transient nausea"
    ],
    "answer": "loss of DTRs",
    "rationale": "High-risk adverse reactions to magnesium sulfate include respiratory depression, loss of DTRs. The nurse must respond to loss of DTRs immediately to prevent deterioration.",
    "choice_rationales": {
      "loss of DTRs": "Correct—loss of DTRs is a serious adverse effect associated with magnesium sulfate and can progress rapidly if unaddressed.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Magnesium sulfate (magnesium sulfate): scenario involves seizure prophylaxis in severe preeclampsia.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "Mg level 7.8 mg/dL; UO 20 mL/hr",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start magnesium sulfate per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0080",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antipsychotic (atypical)",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, olanzapine is prescribed at 10 mg/kg/dose. The child weighs 22 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "120.0 mg",
      "105.0 mg",
      "80.0 mg",
      "100.0 mg"
    ],
    "answer": "100.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "105.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "80.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 22 lb.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start olanzapine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0081",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Insulin (rapid-acting)",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving insulin lispro?",
    "choices": [
      "meal timing",
      "skin turgor",
      "pain score",
      "capillary refill"
    ],
    "answer": "meal timing",
    "rationale": "The key monitoring for insulin lispro includes blood glucose, meal timing; in this case, meal timing is the most safety-critical.",
    "choice_rationales": {
      "meal timing": "Correct—monitoring meal timing detects early complications of insulin lispro and guides safety/therapeutic response.",
      "skin turgor": "Less relevant—skin turgor is not the priority parameter for insulin lispro safety/efficacy.",
      "pain score": "Less relevant—pain score is not the priority parameter for insulin lispro safety/efficacy.",
      "capillary refill": "Less relevant—capillary refill is not the priority parameter for insulin lispro safety/efficacy."
    },
    "case": {
      "tabs": {
        "case_study": "Insulin (rapid-acting) (insulin lispro): scenario involves postprandial hyperglycemia.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0082",
    "bank": "Pharmacology",
    "topic": "Pharmacology - IV potassium",
    "system": "Fluids & Electrolytes/Acid-Base",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the potassium chloride order before administering?",
    "choices": [
      "controlled asthma with no symptoms today",
      "headache rated 3/10",
      "anuria",
      "mild nausea after breakfast"
    ],
    "answer": "anuria",
    "rationale": "potassium chloride should be questioned when anuria is present because it can precipitate severe adverse outcomes (e.g., arrhythmias, phlebitis).",
    "choice_rationales": {
      "controlled asthma with no symptoms today": "Not the best—controlled asthma with no symptoms today does not directly contraindicate potassium chloride in this scenario.",
      "headache rated 3/10": "Not the best—headache rated 3/10 does not directly contraindicate potassium chloride in this scenario.",
      "anuria": "Correct—anuria is a contraindication/major caution for potassium chloride and increases risk of serious harm.",
      "mild nausea after breakfast": "Not the best—mild nausea after breakfast does not directly contraindicate potassium chloride in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "IV potassium (potassium chloride): scenario involves symptomatic hypokalemia.",
        "vitals": "K 5.8 mEq/L, peaked T waves on ECG",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0083",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Loop diuretic",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of furosemide?",
    "choices": [
      "I will stop the medication as soon as I feel better.",
      "eat potassium-rich foods if allowed",
      "Herbal supplements are always safe with prescriptions.",
      "If I miss a dose, I will double the next dose."
    ],
    "answer": "eat potassium-rich foods if allowed",
    "rationale": "Key teaching for furosemide includes: take in morning, change positions slowly. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "eat potassium-rich foods if allowed": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Loop diuretic (furosemide): scenario involves acute pulmonary edema.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start furosemide per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0084",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Heparin (unfractionated)",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with heparin?",
    "choices": [
      "fiber supplement with heparin",
      "aspirin daily with heparin",
      "multivitamin with heparin",
      "acetaminophen (standard dosing) with heparin"
    ],
    "answer": "aspirin daily with heparin",
    "rationale": "High-risk interactions with heparin can cause preventable harm; aspirin daily is concerning because it can ↑bleeding.",
    "choice_rationales": {
      "fiber supplement with heparin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "aspirin daily with heparin": "Correct—aspirin daily can ↑bleeding when combined with heparin.",
      "multivitamin with heparin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "acetaminophen (standard dosing) with heparin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option."
    },
    "case": {
      "tabs": {
        "case_study": "Heparin (unfractionated) (heparin): scenario involves DVT treatment.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start heparin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0085",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Heparin (unfractionated)",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering heparin requires immediate action?",
    "choices": [
      "dry mouth",
      "bleeding",
      "mild headache that resolves with rest",
      "sleepiness after taking the dose"
    ],
    "answer": "bleeding",
    "rationale": "High-risk adverse reactions to heparin include bleeding, HIT, osteoporosis (long term). The nurse must respond to bleeding immediately to prevent deterioration.",
    "choice_rationales": {
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "bleeding": "Correct—bleeding is a serious adverse effect associated with heparin and can progress rapidly if unaddressed.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Heparin (unfractionated) (heparin): scenario involves DVT treatment.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start heparin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0086",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting metformin? Select all that apply.",
    "choices": [
      "Stop the medication when symptoms improve",
      "Share prescription medications with family members if they have similar symptoms",
      "hold for iodinated contrast if ordered",
      "Call the clinic before starting any OTC/herbal products",
      "take with food",
      "Double the next dose if one is missed"
    ],
    "answer": [
      "hold for iodinated contrast if ordered",
      "Call the clinic before starting any OTC/herbal products",
      "take with food"
    ],
    "rationale": "Teaching for metformin must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: take with food, hold for iodinated contrast if ordered.",
    "choice_rationales": {
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "hold for iodinated contrast if ordered": "Correct—supports safe self-management and reduces risk.",
      "Call the clinic before starting any OTC/herbal products": "Correct—supports safe self-management and reduces risk.",
      "take with food": "Correct—supports safe self-management and reduces risk.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start metformin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0087",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Loop diuretic",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the furosemide order?",
    "choices": [
      "Document the dose as given before administering to save time",
      "Skip patient education because the medication is routine",
      "Review the most recent relevant lab value and notify provider if outside parameters",
      "Give the medication first and then check the client’s vitals"
    ],
    "answer": "Review the most recent relevant lab value and notify provider if outside parameters",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering furosemide.",
    "choice_rationales": {
      "Document the dose as given before administering to save time": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Skip patient education because the medication is routine": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Review the most recent relevant lab value and notify provider if outside parameters": "Correct—this action prevents a medication error and aligns with safe administration standards.",
      "Give the medication first and then check the client’s vitals": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment."
    },
    "case": {
      "tabs": {
        "case_study": "Loop diuretic (furosemide): scenario involves acute pulmonary edema.",
        "vitals": "HR 46, BP 92/58, RR 16, SpO2 95% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start furosemide per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0088",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Beta blocker",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering metoprolol, which findings should the nurse monitor closely for potential complications? Select all that apply.",
    "choices": [
      "masking hypoglycemia",
      "fatigue",
      "mild thirst",
      "hypotension",
      "mild hunger",
      "dry skin in winter"
    ],
    "answer": [
      "masking hypoglycemia",
      "fatigue",
      "hypotension"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of metoprolol: bradycardia, hypotension, fatigue.",
    "choice_rationales": {
      "masking hypoglycemia": "Correct—known complication/adverse effect requiring surveillance.",
      "fatigue": "Correct—known complication/adverse effect requiring surveillance.",
      "mild thirst": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "hypotension": "Correct—known complication/adverse effect requiring surveillance.",
      "mild hunger": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "dry skin in winter": "Incorrect—non-specific, not a priority adverse effect for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "Beta blocker (metoprolol): scenario involves rate control in atrial fibrillation.",
        "vitals": "HR 46, BP 92/58, RR 16, SpO2 95% RA",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0089",
    "bank": "Pharmacology",
    "topic": "Pharmacology - TB therapy",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with isoniazid? Select all that apply.",
    "choices": [
      "OTC NSAIDs used daily",
      "Warm compresses",
      "Probiotic yogurt",
      "Alcohol use (2–3 drinks nightly)",
      "Humidifier use",
      "Opioid use while sedated"
    ],
    "answer": [
      "OTC NSAIDs used daily",
      "Alcohol use (2–3 drinks nightly)",
      "Opioid use while sedated"
    ],
    "rationale": "For isoniazid, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "OTC NSAIDs used daily": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Warm compresses": "Incorrect—minimal interaction risk.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "TB therapy (isoniazid): scenario involves latent TB infection.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "AST/ALT elevated; reports numbness/tingling",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0090",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Beta blocker",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering metoprolol, which findings should the nurse monitor closely for potential complications? Select all that apply. (Select the best response.)",
    "choices": [
      "slight fatigue after poor sleep",
      "bradycardia",
      "dry skin in winter",
      "hypotension",
      "mild hunger",
      "fatigue"
    ],
    "answer": [
      "bradycardia",
      "hypotension",
      "fatigue"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of metoprolol: bradycardia, hypotension, fatigue.",
    "choice_rationales": {
      "slight fatigue after poor sleep": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "bradycardia": "Correct—known complication/adverse effect requiring surveillance.",
      "dry skin in winter": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "hypotension": "Correct—known complication/adverse effect requiring surveillance.",
      "mild hunger": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "fatigue": "Correct—known complication/adverse effect requiring surveillance."
    },
    "case": {
      "tabs": {
        "case_study": "Beta blocker (metoprolol): scenario involves rate control in atrial fibrillation.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start metoprolol per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0091",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Immunization",
    "system": "Community/Public Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the influenza vaccine order before administering?",
    "choices": [
      "anaphylaxis to vaccine component",
      "last bowel movement yesterday",
      "history of seasonal allergies (pollen)",
      "controlled asthma with no symptoms today"
    ],
    "answer": "anaphylaxis to vaccine component",
    "rationale": "influenza vaccine should be questioned when anaphylaxis to vaccine component is present because it can precipitate severe adverse outcomes (e.g., local soreness, fever).",
    "choice_rationales": {
      "anaphylaxis to vaccine component": "Correct—anaphylaxis to vaccine component is a contraindication/major caution for influenza vaccine and increases risk of serious harm.",
      "last bowel movement yesterday": "Not the best—last bowel movement yesterday does not directly contraindicate influenza vaccine in this scenario.",
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate influenza vaccine in this scenario.",
      "controlled asthma with no symptoms today": "Not the best—controlled asthma with no symptoms today does not directly contraindicate influenza vaccine in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Immunization (influenza vaccine): scenario involves seasonal prevention.",
        "vitals": "low-grade fever 37.8°C (100°F), HR 92",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start influenza vaccine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0092",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Calcium channel blocker (dihydropyridine)",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of amlodipine?",
    "choices": [
      "I will stop the medication as soon as I feel better.",
      "avoid grapefruit if instructed",
      "I can take this medication with alcohol to help me sleep.",
      "If I miss a dose, I will double the next dose."
    ],
    "answer": "avoid grapefruit if instructed",
    "rationale": "Key teaching for amlodipine includes: monitor for ankle swelling, avoid grapefruit if instructed. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "avoid grapefruit if instructed": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Calcium channel blocker (dihydropyridine) (amlodipine): scenario involves hypertension.",
        "vitals": "HR 46, BP 92/58, RR 16, SpO2 95% RA",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0093",
    "bank": "Pharmacology",
    "topic": "Pharmacology - ACE inhibitor",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with lisinopril? Select all that apply.",
    "choices": [
      "Saline eye drops",
      "Herbal supplement (St. John's wort)",
      "OTC NSAIDs used daily",
      "Opioid use while sedated",
      "Warm compresses",
      "Topical moisturizer"
    ],
    "answer": [
      "Herbal supplement (St. John's wort)",
      "OTC NSAIDs used daily",
      "Opioid use while sedated"
    ],
    "rationale": "For lisinopril, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "Herbal supplement (St. John's wort)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "OTC NSAIDs used daily": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Warm compresses": "Incorrect—minimal interaction risk.",
      "Topical moisturizer": "Incorrect—minimal interaction risk."
    },
    "case": {
      "tabs": {
        "case_study": "ACE inhibitor (lisinopril): scenario involves hypertension with diabetes.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0094",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Sulfonylurea",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving glipizide?",
    "choices": [
      "bowel sounds",
      "pain score",
      "capillary refill",
      "blood glucose"
    ],
    "answer": "blood glucose",
    "rationale": "The key monitoring for glipizide includes blood glucose; in this case, blood glucose is the most safety-critical.",
    "choice_rationales": {
      "bowel sounds": "Less relevant—bowel sounds is not the priority parameter for glipizide safety/efficacy.",
      "pain score": "Less relevant—pain score is not the priority parameter for glipizide safety/efficacy.",
      "capillary refill": "Less relevant—capillary refill is not the priority parameter for glipizide safety/efficacy.",
      "blood glucose": "Correct—monitoring blood glucose detects early complications of glipizide and guides safety/therapeutic response."
    },
    "case": {
      "tabs": {
        "case_study": "Sulfonylurea (glipizide): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0095",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (penicillin)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering amoxicillin, which findings should the nurse monitor closely for potential complications? Select all that apply.",
    "choices": [
      "slight fatigue after poor sleep",
      "increased appetite after meal",
      "mild hunger",
      "mild thirst",
      "allergic reaction",
      "C. diff (rare)"
    ],
    "answer": [
      "allergic reaction",
      "C. diff (rare)"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of amoxicillin: allergic reaction, C. diff (rare).",
    "choice_rationales": {
      "slight fatigue after poor sleep": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "increased appetite after meal": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "mild hunger": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "mild thirst": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "allergic reaction": "Correct—known complication/adverse effect requiring surveillance.",
      "C. diff (rare)": "Correct—known complication/adverse effect requiring surveillance."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (penicillin) (amoxicillin): scenario involves strep pharyngitis.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start amoxicillin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0096",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Anti-emetic",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with ondansetron? Select all that apply.",
    "choices": [
      "Probiotic yogurt",
      "Humidifier use",
      "Opioid use while sedated",
      "Herbal supplement (St. John's wort)",
      "Another QT-prolonging medication",
      "Saline eye drops"
    ],
    "answer": [
      "Opioid use while sedated",
      "Herbal supplement (St. John's wort)",
      "Another QT-prolonging medication"
    ],
    "rationale": "For ondansetron, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Herbal supplement (St. John's wort)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Saline eye drops": "Incorrect—minimal interaction risk."
    },
    "case": {
      "tabs": {
        "case_study": "Anti-emetic (ondansetron): scenario involves postop nausea.",
        "vitals": "black tarry stools, HR 112, BP 96/58",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0097",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (penicillin)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving amoxicillin. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Send the client home because reactions usually resolve without treatment",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Avoid documenting to prevent alarming the client",
      "Offer only ice chips and reassess in 6 hours",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Document the reaction and update the allergy list per policy"
    ],
    "answer": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Document the reaction and update the allergy list per policy"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Send the client home because reactions usually resolve without treatment": "Incorrect—unsafe and does not manage the reaction.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (penicillin) (amoxicillin): scenario involves strep pharyngitis.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0098",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, warfarin is prescribed at 5 mg/kg/dose. The child weighs 22 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "40.0 mg",
      "60.0 mg",
      "55.0 mg",
      "50.0 mg"
    ],
    "answer": "50.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "40.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "60.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "55.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "50.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 22 lb.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0099",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Opioid analgesic",
    "system": "Perioperative/Critical Care",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold morphine and notify the provider? Select all that apply.",
    "choices": [
      "BP 138/84 without symptoms",
      "acute severe asthma",
      "Pain 4/10 relieved with repositioning",
      "respiratory depression",
      "HR 46/min with dizziness",
      "Asks to take medication with orange juice"
    ],
    "answer": [
      "acute severe asthma",
      "respiratory depression",
      "HR 46/min with dizziness"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for morphine plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "acute severe asthma": "Correct—requires holding due to safety risk/contraindication.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "respiratory depression": "Correct—requires holding due to safety risk/contraindication.",
      "HR 46/min with dizziness": "Correct—requires holding due to safety risk/contraindication.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Opioid analgesic (morphine): scenario involves severe postoperative pain.",
        "vitals": "pain 9/10, HR 120, BP 152/88",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0100",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Insulin (rapid-acting)",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold insulin lispro and notify the provider? Select all that apply. (Select the best response.)",
    "choices": [
      "hypoglycemia",
      "BP 138/84 without symptoms",
      "Reports mild nausea",
      "Pain 4/10 relieved with repositioning",
      "Asks to take medication with orange juice",
      "Afebrile temperature 36.8°C (98.2°F)"
    ],
    "answer": [
      "hypoglycemia"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for insulin lispro plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "hypoglycemia": "Correct—requires holding due to safety risk/contraindication.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Insulin (rapid-acting) (insulin lispro): scenario involves postprandial hyperglycemia.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0101",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Immunization",
    "system": "Community/Public Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering influenza vaccine requires immediate action?",
    "choices": [
      "dry mouth",
      "transient nausea",
      "fever",
      "mild headache that resolves with rest"
    ],
    "answer": "fever",
    "rationale": "High-risk adverse reactions to influenza vaccine include local soreness, fever. The nurse must respond to fever immediately to prevent deterioration.",
    "choice_rationales": {
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "fever": "Correct—fever is a serious adverse effect associated with influenza vaccine and can progress rapidly if unaddressed.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Immunization (influenza vaccine): scenario involves seasonal prevention.",
        "vitals": "afebrile, HR 84, BP 124/78",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0102",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Sulfonylurea",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the glipizide order before administering? (Select the best response.)",
    "choices": [
      "last bowel movement yesterday",
      "BP 138/82 with no symptoms",
      "history of seasonal allergies (pollen)",
      "type 1 diabetes"
    ],
    "answer": "type 1 diabetes",
    "rationale": "glipizide should be questioned when type 1 diabetes is present because it can precipitate severe adverse outcomes (e.g., hypoglycemia, weight gain).",
    "choice_rationales": {
      "last bowel movement yesterday": "Not the best—last bowel movement yesterday does not directly contraindicate glipizide in this scenario.",
      "BP 138/82 with no symptoms": "Not the best—BP 138/82 with no symptoms does not directly contraindicate glipizide in this scenario.",
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate glipizide in this scenario.",
      "type 1 diabetes": "Correct—type 1 diabetes is a contraindication/major caution for glipizide and increases risk of serious harm."
    },
    "case": {
      "tabs": {
        "case_study": "Sulfonylurea (glipizide): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start glipizide per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0103",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (macrolide)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of azithromycin? (Select the best response.)",
    "choices": [
      "I will stop the medication as soon as I feel better.",
      "report palpitations/syncope",
      "If I miss a dose, I will double the next dose.",
      "I can take this medication with alcohol to help me sleep."
    ],
    "answer": "report palpitations/syncope",
    "rationale": "Key teaching for azithromycin includes: report palpitations/syncope, complete therapy. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "report palpitations/syncope": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (macrolide) (azithromycin): scenario involves community-acquired pneumonia.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start azithromycin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0104",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Loop diuretic",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving furosemide. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Avoid documenting to prevent alarming the client",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Offer only ice chips and reassess in 6 hours",
      "Send the client home because reactions usually resolve without treatment",
      "Document the reaction and update the allergy list per policy"
    ],
    "answer": [
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Send the client home because reactions usually resolve without treatment": "Incorrect—unsafe and does not manage the reaction.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety."
    },
    "case": {
      "tabs": {
        "case_study": "Loop diuretic (furosemide): scenario involves acute pulmonary edema.",
        "vitals": "HR 46, BP 92/58, RR 16, SpO2 95% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0105",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering oxytocin requires immediate action? (Select the best response.)",
    "choices": [
      "dry mouth",
      "water intoxication (rare)",
      "transient nausea",
      "mild headache that resolves with rest"
    ],
    "answer": "water intoxication (rare)",
    "rationale": "High-risk adverse reactions to oxytocin include uterine tachysystole, water intoxication (rare). The nurse must respond to water intoxication (rare) immediately to prevent deterioration.",
    "choice_rationales": {
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "water intoxication (rare)": "Correct—water intoxication (rare) is a serious adverse effect associated with oxytocin and can progress rapidly if unaddressed.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0106",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antifungal",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting fluconazole? Select all that apply.",
    "choices": [
      "Stop the medication when symptoms improve",
      "Use teach-back to confirm understanding of dosing schedule",
      "report jaundice",
      "avoid pregnancy unless prescribed",
      "Store all medications in the bathroom medicine cabinet",
      "Share prescription medications with family members if they have similar symptoms"
    ],
    "answer": [
      "Use teach-back to confirm understanding of dosing schedule",
      "report jaundice",
      "avoid pregnancy unless prescribed"
    ],
    "rationale": "Teaching for fluconazole must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: avoid pregnancy unless prescribed, report jaundice.",
    "choice_rationales": {
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "report jaundice": "Correct—supports safe self-management and reduces risk.",
      "avoid pregnancy unless prescribed": "Correct—supports safe self-management and reduces risk.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Antifungal (fluconazole): scenario involves vaginal candidiasis.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0107",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Sulfonylurea",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold glipizide and notify the provider? Select all that apply.",
    "choices": [
      "Asks to take medication with orange juice",
      "type 1 diabetes",
      "Reports mild nausea",
      "Afebrile temperature 36.8°C (98.2°F)",
      "BP 138/84 without symptoms",
      "DKA"
    ],
    "answer": [
      "type 1 diabetes",
      "DKA"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for glipizide plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "type 1 diabetes": "Correct—requires holding due to safety risk/contraindication.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "DKA": "Correct—requires holding due to safety risk/contraindication."
    },
    "case": {
      "tabs": {
        "case_study": "Sulfonylurea (glipizide): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start glipizide per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0108",
    "bank": "Pharmacology",
    "topic": "Pharmacology - TB therapy",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with isoniazid? (Select the best response.)",
    "choices": [
      "acetaminophen (standard dosing) with isoniazid",
      "multivitamin with isoniazid",
      "fiber supplement with isoniazid",
      "daily alcohol use with isoniazid"
    ],
    "answer": "daily alcohol use with isoniazid",
    "rationale": "High-risk interactions with isoniazid can cause preventable harm; daily alcohol use is concerning because it can ↑hepatotoxicity.",
    "choice_rationales": {
      "acetaminophen (standard dosing) with isoniazid": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "multivitamin with isoniazid": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "fiber supplement with isoniazid": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "daily alcohol use with isoniazid": "Correct—daily alcohol use can ↑hepatotoxicity when combined with isoniazid."
    },
    "case": {
      "tabs": {
        "case_study": "TB therapy (isoniazid): scenario involves latent TB infection.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "AST/ALT elevated; reports numbness/tingling",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start isoniazid per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0109",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SABA bronchodilator",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of albuterol?",
    "choices": [
      "If I miss a dose, I will double the next dose.",
      "Herbal supplements are always safe with prescriptions.",
      "use rescue first; if using steroid inhaler also, rinse mouth after steroid",
      "I can take this medication with alcohol to help me sleep."
    ],
    "answer": "use rescue first; if using steroid inhaler also, rinse mouth after steroid",
    "rationale": "Key teaching for albuterol includes: use rescue first; if using steroid inhaler also, rinse mouth after steroid. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "use rescue first; if using steroid inhaler also, rinse mouth after steroid": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "SABA bronchodilator (albuterol): scenario involves acute bronchospasm.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0110",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (macrolide)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the azithromycin order?",
    "choices": [
      "Document the dose as given before administering to save time",
      "Give the medication first and then check the client’s vitals",
      "Assess the parameter that determines whether to hold the medication (per protocol) before giving",
      "Ask the family to decide whether the client wants the medication today"
    ],
    "answer": "Assess the parameter that determines whether to hold the medication (per protocol) before giving",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering azithromycin.",
    "choice_rationales": {
      "Document the dose as given before administering to save time": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Give the medication first and then check the client’s vitals": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Assess the parameter that determines whether to hold the medication (per protocol) before giving": "Correct—this action prevents a medication error and aligns with safe administration standards.",
      "Ask the family to decide whether the client wants the medication today": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (macrolide) (azithromycin): scenario involves community-acquired pneumonia.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0111",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Thyroid hormone",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving levothyroxine?",
    "choices": [
      "pain score",
      "daily calorie count",
      "HR",
      "capillary refill"
    ],
    "answer": "HR",
    "rationale": "The key monitoring for levothyroxine includes TSH, HR; in this case, HR is the most safety-critical.",
    "choice_rationales": {
      "pain score": "Less relevant—pain score is not the priority parameter for levothyroxine safety/efficacy.",
      "daily calorie count": "Less relevant—daily calorie count is not the priority parameter for levothyroxine safety/efficacy.",
      "HR": "Correct—monitoring HR detects early complications of levothyroxine and guides safety/therapeutic response.",
      "capillary refill": "Less relevant—capillary refill is not the priority parameter for levothyroxine safety/efficacy."
    },
    "case": {
      "tabs": {
        "case_study": "Thyroid hormone (levothyroxine): scenario involves hypothyroidism.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0112",
    "bank": "Pharmacology",
    "topic": "Pharmacology - TB therapy",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with isoniazid? Select all that apply. (Select the best response.)",
    "choices": [
      "Warm compresses",
      "Saline eye drops",
      "Topical moisturizer",
      "Potassium-containing salt substitute",
      "Alcohol use (2–3 drinks nightly)",
      "Herbal supplement (St. John's wort)"
    ],
    "answer": [
      "Potassium-containing salt substitute",
      "Alcohol use (2–3 drinks nightly)",
      "Herbal supplement (St. John's wort)"
    ],
    "rationale": "For isoniazid, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Warm compresses": "Incorrect—minimal interaction risk.",
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Potassium-containing salt substitute": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Herbal supplement (St. John's wort)": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "TB therapy (isoniazid): scenario involves latent TB infection.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "AST/ALT elevated; reports numbness/tingling",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start isoniazid per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0113",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold oxytocin and notify the provider? Select all that apply.",
    "choices": [
      "fetal distress without delivery imminent",
      "Asks to take medication with orange juice",
      "Pain 4/10 relieved with repositioning",
      "Afebrile temperature 36.8°C (98.2°F)",
      "BP 138/84 without symptoms",
      "uterine rupture risk (relative)"
    ],
    "answer": [
      "fetal distress without delivery imminent",
      "uterine rupture risk (relative)"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for oxytocin plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "fetal distress without delivery imminent": "Correct—requires holding due to safety risk/contraindication.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "uterine rupture risk (relative)": "Correct—requires holding due to safety risk/contraindication."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0114",
    "bank": "Pharmacology",
    "topic": "Pharmacology - NSAID",
    "system": "Musculoskeletal",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the ibuprofen order?",
    "choices": [
      "Skip patient education because the medication is routine",
      "Ask the family to decide whether the client wants the medication today",
      "Document the dose as given before administering to save time",
      "Verify the order, allergies, and two patient identifiers before administration"
    ],
    "answer": "Verify the order, allergies, and two patient identifiers before administration",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering ibuprofen.",
    "choice_rationales": {
      "Skip patient education because the medication is routine": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Ask the family to decide whether the client wants the medication today": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Document the dose as given before administering to save time": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Verify the order, allergies, and two patient identifiers before administration": "Correct—this action prevents a medication error and aligns with safe administration standards."
    },
    "case": {
      "tabs": {
        "case_study": "NSAID (ibuprofen): scenario involves acute musculoskeletal pain.",
        "vitals": "pain 7/10, HR 96, BP 136/82",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0115",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Magnesium sulfate",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the magnesium sulfate order before administering? (Select the best response.)",
    "choices": [
      "history of seasonal allergies (pollen)",
      "myasthenia gravis",
      "headache rated 3/10",
      "mild nausea after breakfast"
    ],
    "answer": "myasthenia gravis",
    "rationale": "magnesium sulfate should be questioned when myasthenia gravis is present because it can precipitate severe adverse outcomes (e.g., respiratory depression, loss of DTRs).",
    "choice_rationales": {
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate magnesium sulfate in this scenario.",
      "myasthenia gravis": "Correct—myasthenia gravis is a contraindication/major caution for magnesium sulfate and increases risk of serious harm.",
      "headache rated 3/10": "Not the best—headache rated 3/10 does not directly contraindicate magnesium sulfate in this scenario.",
      "mild nausea after breakfast": "Not the best—mild nausea after breakfast does not directly contraindicate magnesium sulfate in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Magnesium sulfate (magnesium sulfate): scenario involves seizure prophylaxis in severe preeclampsia.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "Mg level 7.8 mg/dL; UO 20 mL/hr",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start magnesium sulfate per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0116",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the warfarin order before administering?",
    "choices": [
      "history of seasonal allergies (pollen)",
      "mild nausea after breakfast",
      "last bowel movement yesterday",
      "pregnancy"
    ],
    "answer": "pregnancy",
    "rationale": "warfarin should be questioned when pregnancy is present because it can precipitate severe adverse outcomes (e.g., bleeding, skin necrosis (rare)).",
    "choice_rationales": {
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate warfarin in this scenario.",
      "mild nausea after breakfast": "Not the best—mild nausea after breakfast does not directly contraindicate warfarin in this scenario.",
      "last bowel movement yesterday": "Not the best—last bowel movement yesterday does not directly contraindicate warfarin in this scenario.",
      "pregnancy": "Correct—pregnancy is a contraindication/major caution for warfarin and increases risk of serious harm."
    },
    "case": {
      "tabs": {
        "case_study": "Warfarin (warfarin): scenario involves stroke prevention in atrial fibrillation.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0117",
    "bank": "Pharmacology",
    "topic": "Pharmacology - PPI",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting pantoprazole? Select all that apply.",
    "choices": [
      "take before meals",
      "Share prescription medications with family members if they have similar symptoms",
      "report persistent diarrhea",
      "Store all medications in the bathroom medicine cabinet",
      "Keep an updated medication list and share it at every visit",
      "Double the next dose if one is missed"
    ],
    "answer": [
      "take before meals",
      "report persistent diarrhea",
      "Keep an updated medication list and share it at every visit"
    ],
    "rationale": "Teaching for pantoprazole must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: take before meals, report persistent diarrhea.",
    "choice_rationales": {
      "take before meals": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "report persistent diarrhea": "Correct—supports safe self-management and reduces risk.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Keep an updated medication list and share it at every visit": "Correct—supports safe self-management and reduces risk.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "PPI (pantoprazole): scenario involves stress ulcer prophylaxis ICU.",
        "vitals": "N/V, HR 98, BP 122/74, dry mucosa",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0118",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antipsychotic (atypical)",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting olanzapine? Select all that apply. (Select the best response.)",
    "choices": [
      "Keep an updated medication list and share it at every visit",
      "monitor diet/exercise",
      "Share prescription medications with family members if they have similar symptoms",
      "Double the next dose if one is missed",
      "Stop the medication when symptoms improve",
      "report uncontrolled movements"
    ],
    "answer": [
      "Keep an updated medication list and share it at every visit",
      "monitor diet/exercise",
      "report uncontrolled movements"
    ],
    "rationale": "Teaching for olanzapine must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: report uncontrolled movements, monitor diet/exercise.",
    "choice_rationales": {
      "Keep an updated medication list and share it at every visit": "Correct—supports safe self-management and reduces risk.",
      "monitor diet/exercise": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "report uncontrolled movements": "Correct—supports safe self-management and reduces risk."
    },
    "case": {
      "tabs": {
        "case_study": "Antipsychotic (atypical) (olanzapine): scenario involves acute mania.",
        "vitals": "anxious, HR 126, BP 140/86, RR 22",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0119",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting metformin? Select all that apply. (Select the best response.)",
    "choices": [
      "hold for iodinated contrast if ordered",
      "take with food",
      "Keep an updated medication list and share it at every visit",
      "Double the next dose if one is missed",
      "Store all medications in the bathroom medicine cabinet",
      "Share prescription medications with family members if they have similar symptoms"
    ],
    "answer": [
      "hold for iodinated contrast if ordered",
      "take with food",
      "Keep an updated medication list and share it at every visit"
    ],
    "rationale": "Teaching for metformin must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: take with food, hold for iodinated contrast if ordered.",
    "choice_rationales": {
      "hold for iodinated contrast if ordered": "Correct—supports safe self-management and reduces risk.",
      "take with food": "Correct—supports safe self-management and reduces risk.",
      "Keep an updated medication list and share it at every visit": "Correct—supports safe self-management and reduces risk.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0120",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (vancomycin)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, vancomycin is prescribed at 5 mg/kg/dose. The child weighs 55 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "150.0 mg",
      "100.0 mg",
      "130.0 mg",
      "125.0 mg"
    ],
    "answer": "125.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "150.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "130.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "125.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 55 lb.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "Cr 1.6 (up from 1.0); vanc trough 24 mcg/mL",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0121",
    "bank": "Pharmacology",
    "topic": "Pharmacology - NSAID",
    "system": "Musculoskeletal",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering ibuprofen, which findings should the nurse monitor closely for potential complications? Select all that apply. (Select the best response.)",
    "choices": [
      "slight fatigue after poor sleep",
      "GI ulcer/bleed",
      "mild hunger",
      "increased BP",
      "renal injury",
      "increased appetite after meal"
    ],
    "answer": [
      "GI ulcer/bleed",
      "increased BP",
      "renal injury"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of ibuprofen: GI ulcer/bleed, renal injury, increased BP.",
    "choice_rationales": {
      "slight fatigue after poor sleep": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "GI ulcer/bleed": "Correct—known complication/adverse effect requiring surveillance.",
      "mild hunger": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "increased BP": "Correct—known complication/adverse effect requiring surveillance.",
      "renal injury": "Correct—known complication/adverse effect requiring surveillance.",
      "increased appetite after meal": "Incorrect—non-specific, not a priority adverse effect for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "NSAID (ibuprofen): scenario involves acute musculoskeletal pain.",
        "vitals": "pain 7/10, HR 96, BP 136/82",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0122",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the metformin order before administering? (Select the best response.)",
    "choices": [
      "controlled asthma with no symptoms today",
      "BP 138/82 with no symptoms",
      "acute metabolic acidosis",
      "headache rated 3/10"
    ],
    "answer": "acute metabolic acidosis",
    "rationale": "metformin should be questioned when acute metabolic acidosis is present because it can precipitate severe adverse outcomes (e.g., GI upset, lactic acidosis (rare)).",
    "choice_rationales": {
      "controlled asthma with no symptoms today": "Not the best—controlled asthma with no symptoms today does not directly contraindicate metformin in this scenario.",
      "BP 138/82 with no symptoms": "Not the best—BP 138/82 with no symptoms does not directly contraindicate metformin in this scenario.",
      "acute metabolic acidosis": "Correct—acute metabolic acidosis is a contraindication/major caution for metformin and increases risk of serious harm.",
      "headache rated 3/10": "Not the best—headache rated 3/10 does not directly contraindicate metformin in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0123",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Loop diuretic",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering furosemide, which findings should the nurse monitor closely for potential complications? Select all that apply.",
    "choices": [
      "dry skin in winter",
      "increased appetite after meal",
      "dehydration",
      "hypokalemia",
      "ototoxicity (high dose IV)",
      "slight fatigue after poor sleep"
    ],
    "answer": [
      "dehydration",
      "hypokalemia",
      "ototoxicity (high dose IV)"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of furosemide: hypokalemia, ototoxicity (high dose IV), dehydration.",
    "choice_rationales": {
      "dry skin in winter": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "increased appetite after meal": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "dehydration": "Correct—known complication/adverse effect requiring surveillance.",
      "hypokalemia": "Correct—known complication/adverse effect requiring surveillance.",
      "ototoxicity (high dose IV)": "Correct—known complication/adverse effect requiring surveillance.",
      "slight fatigue after poor sleep": "Incorrect—non-specific, not a priority adverse effect for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "Loop diuretic (furosemide): scenario involves acute pulmonary edema.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0124",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Inhaled corticosteroid",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold fluticasone and notify the provider? Select all that apply.",
    "choices": [
      "acute bronchospasm",
      "BP 138/84 without symptoms",
      "Reports mild nausea",
      "Afebrile temperature 36.8°C (98.2°F)",
      "Pain 4/10 relieved with repositioning",
      "Asks to take medication with orange juice"
    ],
    "answer": [
      "acute bronchospasm"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for fluticasone plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "acute bronchospasm": "Correct—requires holding due to safety risk/contraindication.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Inhaled corticosteroid (fluticasone): scenario involves asthma control.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start fluticasone per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0125",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Thyroid hormone",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the levothyroxine is achieving the intended therapeutic effect? (Select the best response.)",
    "choices": [
      "TSH trending toward target and improved energy",
      "new onset dizziness when standing",
      "worsening lab abnormalities",
      "no symptom change after several doses"
    ],
    "answer": "TSH trending toward target and improved energy",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (hypothyroidism). The best indicator is: TSH trending toward target and improved energy.",
    "choice_rationales": {
      "TSH trending toward target and improved energy": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Thyroid hormone (levothyroxine): scenario involves hypothyroidism.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start levothyroxine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0126",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antiepileptic",
    "system": "Neurologic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering phenytoin, which findings should the nurse monitor closely for potential complications? Select all that apply.",
    "choices": [
      "rash (SJS)",
      "gingival hyperplasia",
      "dry skin in winter",
      "increased appetite after meal",
      "mild thirst",
      "ataxia"
    ],
    "answer": [
      "rash (SJS)",
      "gingival hyperplasia",
      "ataxia"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of phenytoin: gingival hyperplasia, rash (SJS), ataxia.",
    "choice_rationales": {
      "rash (SJS)": "Correct—known complication/adverse effect requiring surveillance.",
      "gingival hyperplasia": "Correct—known complication/adverse effect requiring surveillance.",
      "dry skin in winter": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "increased appetite after meal": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "mild thirst": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "ataxia": "Correct—known complication/adverse effect requiring surveillance."
    },
    "case": {
      "tabs": {
        "case_study": "Antiepileptic (phenytoin): scenario involves seizure prevention.",
        "vitals": "GCS 14, pupils equal, HR 88, BP 150/88",
        "labs": "phenytoin level 24 mcg/mL; nystagmus noted",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0127",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SABA bronchodilator",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering albuterol requires immediate action? (Select the best response.)",
    "choices": [
      "sleepiness after taking the dose",
      "transient nausea",
      "dry mouth",
      "tachycardia"
    ],
    "answer": "tachycardia",
    "rationale": "High-risk adverse reactions to albuterol include tachycardia, tremor, hypokalemia (high dose). The nurse must respond to tachycardia immediately to prevent deterioration.",
    "choice_rationales": {
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "tachycardia": "Correct—tachycardia is a serious adverse effect associated with albuterol and can progress rapidly if unaddressed."
    },
    "case": {
      "tabs": {
        "case_study": "SABA bronchodilator (albuterol): scenario involves acute bronchospasm.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start albuterol per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0128",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Heparin (unfractionated)",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering heparin requires immediate action? (Select the best response.)",
    "choices": [
      "mild headache that resolves with rest",
      "dry mouth",
      "HIT",
      "transient nausea"
    ],
    "answer": "HIT",
    "rationale": "High-risk adverse reactions to heparin include bleeding, HIT, osteoporosis (long term). The nurse must respond to HIT immediately to prevent deterioration.",
    "choice_rationales": {
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "HIT": "Correct—HIT is a serious adverse effect associated with heparin and can progress rapidly if unaddressed.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Heparin (unfractionated) (heparin): scenario involves DVT treatment.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0129",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Magnesium sulfate",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold magnesium sulfate and notify the provider? Select all that apply.",
    "choices": [
      "Asks to take medication with orange juice",
      "Reports mild nausea",
      "Afebrile temperature 36.8°C (98.2°F)",
      "RR 10/min and absent deep tendon reflexes",
      "Pain 4/10 relieved with repositioning",
      "myasthenia gravis"
    ],
    "answer": [
      "RR 10/min and absent deep tendon reflexes",
      "myasthenia gravis"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for magnesium sulfate plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "RR 10/min and absent deep tendon reflexes": "Correct—requires holding due to safety risk/contraindication.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "myasthenia gravis": "Correct—requires holding due to safety risk/contraindication."
    },
    "case": {
      "tabs": {
        "case_study": "Magnesium sulfate (magnesium sulfate): scenario involves seizure prophylaxis in severe preeclampsia.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "Mg level 7.8 mg/dL; UO 20 mL/hr",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start magnesium sulfate per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0130",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Heparin (unfractionated)",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, heparin is infusing at 25,000 units in 250 mL D5W. The order is 1,250 units/hr. At what rate (mL/hr) should the nurse set the pump?",
    "choices": [
      "15 mL/hr",
      "10 mL/hr",
      "12.5 mL/hr",
      "11.5 mL/hr"
    ],
    "answer": "12.5 mL/hr",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "15 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "10 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "12.5 mL/hr": "Correct—calculation and/or unit conversion matches the order.",
      "11.5 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Heparin (unfractionated) (heparin): scenario involves DVT treatment.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0131",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering warfarin requires immediate action?",
    "choices": [
      "mild headache that resolves with rest",
      "bleeding",
      "dry mouth",
      "sleepiness after taking the dose"
    ],
    "answer": "bleeding",
    "rationale": "High-risk adverse reactions to warfarin include bleeding, skin necrosis (rare). The nurse must respond to bleeding immediately to prevent deterioration.",
    "choice_rationales": {
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "bleeding": "Correct—bleeding is a serious adverse effect associated with warfarin and can progress rapidly if unaddressed.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Warfarin (warfarin): scenario involves stroke prevention in atrial fibrillation.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start warfarin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0132",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Benzodiazepine",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the lorazepam is achieving the intended therapeutic effect? (Select the best response.)",
    "choices": [
      "worsening lab abnormalities",
      "symptom improvement with stable vital signs and target lab trends",
      "development of rash and wheeze",
      "no symptom change after several doses"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (acute severe anxiety). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Benzodiazepine (lorazepam): scenario involves acute severe anxiety.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start lorazepam per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0133",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, warfarin is prescribed at 10 mg/kg/dose. The child weighs 33 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "120.0 mg",
      "180.0 mg",
      "150.0 mg",
      "155.0 mg"
    ],
    "answer": "150.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "180.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "150.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "155.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 33 lb.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0134",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Inhaled corticosteroid",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with fluticasone? Select all that apply.",
    "choices": [
      "Topical moisturizer",
      "Alcohol use (2–3 drinks nightly)",
      "Humidifier use",
      "Saline eye drops",
      "Another QT-prolonging medication",
      "OTC NSAIDs used daily"
    ],
    "answer": [
      "Alcohol use (2–3 drinks nightly)",
      "Another QT-prolonging medication",
      "OTC NSAIDs used daily"
    ],
    "rationale": "For fluticasone, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "OTC NSAIDs used daily": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Inhaled corticosteroid (fluticasone): scenario involves asthma control.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start fluticasone per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0135",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Insulin (rapid-acting)",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the insulin lispro order?",
    "choices": [
      "Ask the family to decide whether the client wants the medication today",
      "Give the medication first and then check the client’s vitals",
      "Skip patient education because the medication is routine",
      "Review the most recent relevant lab value and notify provider if outside parameters"
    ],
    "answer": "Review the most recent relevant lab value and notify provider if outside parameters",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering insulin lispro.",
    "choice_rationales": {
      "Ask the family to decide whether the client wants the medication today": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Give the medication first and then check the client’s vitals": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Skip patient education because the medication is routine": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Review the most recent relevant lab value and notify provider if outside parameters": "Correct—this action prevents a medication error and aligns with safe administration standards."
    },
    "case": {
      "tabs": {
        "case_study": "Insulin (rapid-acting) (insulin lispro): scenario involves postprandial hyperglycemia.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start insulin lispro per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0136",
    "bank": "Pharmacology",
    "topic": "Pharmacology - IV potassium",
    "system": "Fluids & Electrolytes/Acid-Base",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, potassium chloride 20 mEq in 100 mL is ordered to infuse over 2 hours. What rate (mL/hr) should the nurse program?",
    "choices": [
      "50 mL/hr",
      "100 mL/hr",
      "25 mL/hr",
      "75 mL/hr"
    ],
    "answer": "50 mL/hr",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "50 mL/hr": "Correct—calculation and/or unit conversion matches the order.",
      "100 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "25 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "75 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "IV potassium (potassium chloride): scenario involves symptomatic hypokalemia.",
        "vitals": "K 2.9 mEq/L, HR 118 with PVCs, BP 104/62",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0137",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Sulfonylurea",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the glipizide is achieving the intended therapeutic effect?",
    "choices": [
      "development of rash and wheeze",
      "worsening lab abnormalities",
      "no symptom change after several doses",
      "symptom improvement with stable vital signs and target lab trends"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (type 2 diabetes). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication."
    },
    "case": {
      "tabs": {
        "case_study": "Sulfonylurea (glipizide): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0138",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Inhaled corticosteroid",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting fluticasone? Select all that apply.",
    "choices": [
      "Share prescription medications with family members if they have similar symptoms",
      "not for acute attacks",
      "Stop the medication when symptoms improve",
      "Store all medications in the bathroom medicine cabinet",
      "Use teach-back to confirm understanding of dosing schedule",
      "rinse mouth after use"
    ],
    "answer": [
      "not for acute attacks",
      "Use teach-back to confirm understanding of dosing schedule",
      "rinse mouth after use"
    ],
    "rationale": "Teaching for fluticasone must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: rinse mouth after use, not for acute attacks.",
    "choice_rationales": {
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "not for acute attacks": "Correct—supports safe self-management and reduces risk.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "rinse mouth after use": "Correct—supports safe self-management and reduces risk."
    },
    "case": {
      "tabs": {
        "case_study": "Inhaled corticosteroid (fluticasone): scenario involves asthma control.",
        "vitals": "RR 28, SpO2 88% RA, HR 110, BP 142/86",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0139",
    "bank": "Pharmacology",
    "topic": "Pharmacology - NSAID",
    "system": "Musculoskeletal",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with ibuprofen? (Select the best response.)",
    "choices": [
      "calcium carbonate with ibuprofen",
      "alcohol use with ibuprofen",
      "multivitamin with ibuprofen",
      "acetaminophen (standard dosing) with ibuprofen"
    ],
    "answer": "alcohol use with ibuprofen",
    "rationale": "High-risk interactions with ibuprofen can cause preventable harm; alcohol use is concerning because it can increases adverse effects.",
    "choice_rationales": {
      "calcium carbonate with ibuprofen": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "alcohol use with ibuprofen": "Correct—alcohol use can increases adverse effects when combined with ibuprofen.",
      "multivitamin with ibuprofen": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "acetaminophen (standard dosing) with ibuprofen": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option."
    },
    "case": {
      "tabs": {
        "case_study": "NSAID (ibuprofen): scenario involves acute musculoskeletal pain.",
        "vitals": "pain 7/10, HR 96, BP 136/82",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start ibuprofen per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0140",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Heparin (unfractionated)",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, heparin is infusing at 25,000 units in 250 mL D5W. The order is 1,250 units/hr. At what rate (mL/hr) should the nurse set the pump? (Select the best response.)",
    "choices": [
      "10 mL/hr",
      "12.5 mL/hr",
      "15 mL/hr",
      "11.5 mL/hr"
    ],
    "answer": "12.5 mL/hr",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "10 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "12.5 mL/hr": "Correct—calculation and/or unit conversion matches the order.",
      "15 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "11.5 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Heparin (unfractionated) (heparin): scenario involves DVT treatment.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0141",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SSRI",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering sertraline, which findings should the nurse monitor closely for potential complications? Select all that apply.",
    "choices": [
      "GI upset",
      "dry skin in winter",
      "sexual dysfunction",
      "mild hunger",
      "serotonin syndrome (rare)",
      "slight fatigue after poor sleep"
    ],
    "answer": [
      "GI upset",
      "sexual dysfunction",
      "serotonin syndrome (rare)"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of sertraline: GI upset, sexual dysfunction, serotonin syndrome (rare).",
    "choice_rationales": {
      "GI upset": "Correct—known complication/adverse effect requiring surveillance.",
      "dry skin in winter": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "sexual dysfunction": "Correct—known complication/adverse effect requiring surveillance.",
      "mild hunger": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "serotonin syndrome (rare)": "Correct—known complication/adverse effect requiring surveillance.",
      "slight fatigue after poor sleep": "Incorrect—non-specific, not a priority adverse effect for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "SSRI (sertraline): scenario involves major depressive disorder.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start sertraline per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0142",
    "bank": "Pharmacology",
    "topic": "Pharmacology - PPI",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving pantoprazole. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy",
      "Offer only ice chips and reassess in 6 hours",
      "Avoid documenting to prevent alarming the client",
      "Give the next dose early to overcome the reaction",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability"
    ],
    "answer": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Give the next dose early to overcome the reaction": "Incorrect—unsafe and does not manage the reaction.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety."
    },
    "case": {
      "tabs": {
        "case_study": "PPI (pantoprazole): scenario involves stress ulcer prophylaxis ICU.",
        "vitals": "black tarry stools, HR 112, BP 96/58",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0143",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (macrolide)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with azithromycin? Select all that apply.",
    "choices": [
      "Potassium-containing salt substitute",
      "Probiotic yogurt",
      "Topical moisturizer",
      "Another QT-prolonging medication",
      "Saline eye drops",
      "Opioid use while sedated"
    ],
    "answer": [
      "Potassium-containing salt substitute",
      "Another QT-prolonging medication",
      "Opioid use while sedated"
    ],
    "rationale": "For azithromycin, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Potassium-containing salt substitute": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (macrolide) (azithromycin): scenario involves community-acquired pneumonia.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start azithromycin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0144",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Opioid analgesic",
    "system": "Perioperative/Critical Care",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving morphine. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Avoid documenting to prevent alarming the client",
      "Prepare and administer reversal agent per order/protocol (e.g., naloxone) and support ventilation",
      "Document the reaction and update the allergy list per policy",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Offer only ice chips and reassess in 6 hours"
    ],
    "answer": [
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Prepare and administer reversal agent per order/protocol (e.g., naloxone) and support ventilation",
      "Document the reaction and update the allergy list per policy",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Prepare and administer reversal agent per order/protocol (e.g., naloxone) and support ventilation": "Correct—aligns with adverse reaction management and patient safety.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction."
    },
    "case": {
      "tabs": {
        "case_study": "Opioid analgesic (morphine): scenario involves severe postoperative pain.",
        "vitals": "RR 8, SpO2 90% on 2L NC, HR 58, BP 86/48",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0145",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of metformin?",
    "choices": [
      "I can take this medication with alcohol to help me sleep.",
      "If I miss a dose, I will double the next dose.",
      "take with food",
      "Herbal supplements are always safe with prescriptions."
    ],
    "answer": "take with food",
    "rationale": "Key teaching for metformin includes: take with food, hold for iodinated contrast if ordered. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "take with food": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0146",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Sulfonylurea",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering glipizide, which findings should the nurse monitor closely for potential complications? Select all that apply.",
    "choices": [
      "mild thirst",
      "increased appetite after meal",
      "hypoglycemia",
      "weight gain",
      "dry skin in winter",
      "slight fatigue after poor sleep"
    ],
    "answer": [
      "hypoglycemia",
      "weight gain"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of glipizide: hypoglycemia, weight gain.",
    "choice_rationales": {
      "mild thirst": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "increased appetite after meal": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "hypoglycemia": "Correct—known complication/adverse effect requiring surveillance.",
      "weight gain": "Correct—known complication/adverse effect requiring surveillance.",
      "dry skin in winter": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "slight fatigue after poor sleep": "Incorrect—non-specific, not a priority adverse effect for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "Sulfonylurea (glipizide): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start glipizide per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0147",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antifungal",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, fluconazole is prescribed at 5 mg/kg/dose. The child weighs 33 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "90.0 mg",
      "75.0 mg",
      "80.0 mg",
      "60.0 mg"
    ],
    "answer": "75.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "90.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "75.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "80.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "60.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 33 lb.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0148",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antipsychotic (atypical)",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with olanzapine? Select all that apply.",
    "choices": [
      "Herbal supplement (St. John's wort)",
      "OTC NSAIDs used daily",
      "Opioid use while sedated",
      "Saline eye drops",
      "Humidifier use",
      "Warm compresses"
    ],
    "answer": [
      "Herbal supplement (St. John's wort)",
      "OTC NSAIDs used daily",
      "Opioid use while sedated"
    ],
    "rationale": "For olanzapine, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Herbal supplement (St. John's wort)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "OTC NSAIDs used daily": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Warm compresses": "Incorrect—minimal interaction risk."
    },
    "case": {
      "tabs": {
        "case_study": "Antipsychotic (atypical) (olanzapine): scenario involves acute mania.",
        "vitals": "anxious, HR 126, BP 140/86, RR 22",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0149",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Anti-emetic",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering ondansetron requires immediate action?",
    "choices": [
      "dry mouth",
      "QT prolongation",
      "mild headache that resolves with rest",
      "sleepiness after taking the dose"
    ],
    "answer": "QT prolongation",
    "rationale": "High-risk adverse reactions to ondansetron include QT prolongation, constipation, headache. The nurse must respond to QT prolongation immediately to prevent deterioration.",
    "choice_rationales": {
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "QT prolongation": "Correct—QT prolongation is a serious adverse effect associated with ondansetron and can progress rapidly if unaddressed.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Anti-emetic (ondansetron): scenario involves postop nausea.",
        "vitals": "black tarry stools, HR 112, BP 96/58",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0150",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, oxytocin is prescribed at 10 mg/kg/dose. The child weighs 22 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "80.0 mg",
      "100.0 mg",
      "120.0 mg",
      "105.0 mg"
    ],
    "answer": "100.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "80.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "105.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 22 lb.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0151",
    "bank": "Pharmacology",
    "topic": "Pharmacology - TB therapy",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the isoniazid is achieving the intended therapeutic effect?",
    "choices": [
      "new onset dizziness when standing",
      "development of rash and wheeze",
      "symptom improvement with stable vital signs and target lab trends",
      "worsening lab abnormalities"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (latent TB infection). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "TB therapy (isoniazid): scenario involves latent TB infection.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "AST/ALT elevated; reports numbness/tingling",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start isoniazid per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0152",
    "bank": "Pharmacology",
    "topic": "Pharmacology - ACE inhibitor",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, lisinopril is prescribed at 10 mg/kg/dose. The child weighs 55 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "250.0 mg",
      "300.0 mg",
      "200.0 mg",
      "255.0 mg"
    ],
    "answer": "250.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "250.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "300.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "200.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "255.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 55 lb.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0153",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antiepileptic",
    "system": "Neurologic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold phenytoin and notify the provider? Select all that apply. (Select the best response.)",
    "choices": [
      "BP 138/84 without symptoms",
      "sinus bradycardia/SA block (IV)",
      "Reports mild nausea",
      "Asks to take medication with orange juice",
      "Afebrile temperature 36.8°C (98.2°F)",
      "Pain 4/10 relieved with repositioning"
    ],
    "answer": [
      "sinus bradycardia/SA block (IV)"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for phenytoin plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "sinus bradycardia/SA block (IV)": "Correct—requires holding due to safety risk/contraindication.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Antiepileptic (phenytoin): scenario involves seizure prevention.",
        "vitals": "GCS 14, pupils equal, HR 88, BP 150/88",
        "labs": "phenytoin level 24 mcg/mL; nystagmus noted",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0154",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of metformin? (Select the best response.)",
    "choices": [
      "I will stop the medication as soon as I feel better.",
      "Herbal supplements are always safe with prescriptions.",
      "hold for iodinated contrast if ordered",
      "If I miss a dose, I will double the next dose."
    ],
    "answer": "hold for iodinated contrast if ordered",
    "rationale": "Key teaching for metformin includes: take with food, hold for iodinated contrast if ordered. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "hold for iodinated contrast if ordered": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start metformin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0155",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antipsychotic (atypical)",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, olanzapine is prescribed at 5 mg/kg/dose. The child weighs 55 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "100.0 mg",
      "150.0 mg",
      "130.0 mg",
      "125.0 mg"
    ],
    "answer": "125.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "100.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "150.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "130.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "125.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 55 lb.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start olanzapine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0156",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (penicillin)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the amoxicillin is achieving the intended therapeutic effect?",
    "choices": [
      "development of rash and wheeze",
      "symptom improvement with stable vital signs and target lab trends",
      "new onset dizziness when standing",
      "worsening lab abnormalities"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (strep pharyngitis). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (penicillin) (amoxicillin): scenario involves strep pharyngitis.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0157",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Loop diuretic",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of furosemide? (Select the best response.)",
    "choices": [
      "Herbal supplements are always safe with prescriptions.",
      "I will stop the medication as soon as I feel better.",
      "I can take this medication with alcohol to help me sleep.",
      "eat potassium-rich foods if allowed"
    ],
    "answer": "eat potassium-rich foods if allowed",
    "rationale": "Key teaching for furosemide includes: take in morning, change positions slowly. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "eat potassium-rich foods if allowed": "Correct—this statement reflects safe, accurate self-management for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "Loop diuretic (furosemide): scenario involves acute pulmonary edema.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0158",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting oxytocin? Select all that apply.",
    "choices": [
      "report severe pain; continuous monitoring",
      "Stop the medication when symptoms improve",
      "Use teach-back to confirm understanding of dosing schedule",
      "Store all medications in the bathroom medicine cabinet",
      "Share prescription medications with family members if they have similar symptoms"
    ],
    "answer": [
      "report severe pain; continuous monitoring",
      "Use teach-back to confirm understanding of dosing schedule"
    ],
    "rationale": "Teaching for oxytocin must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: report severe pain; continuous monitoring.",
    "choice_rationales": {
      "report severe pain; continuous monitoring": "Correct—supports safe self-management and reduces risk.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0159",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SSRI",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving sertraline. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Offer only ice chips and reassess in 6 hours",
      "Send the client home because reactions usually resolve without treatment",
      "Give the next dose early to overcome the reaction",
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability"
    ],
    "answer": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Send the client home because reactions usually resolve without treatment": "Incorrect—unsafe and does not manage the reaction.",
      "Give the next dose early to overcome the reaction": "Incorrect—unsafe and does not manage the reaction.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety."
    },
    "case": {
      "tabs": {
        "case_study": "SSRI (sertraline): scenario involves major depressive disorder.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start sertraline per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0160",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Anti-emetic",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the ondansetron order? (Select the best response.)",
    "choices": [
      "Give the medication first and then check the client’s vitals",
      "Review the most recent relevant lab value and notify provider if outside parameters",
      "Document the dose as given before administering to save time",
      "Skip patient education because the medication is routine"
    ],
    "answer": "Review the most recent relevant lab value and notify provider if outside parameters",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering ondansetron.",
    "choice_rationales": {
      "Give the medication first and then check the client’s vitals": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Review the most recent relevant lab value and notify provider if outside parameters": "Correct—this action prevents a medication error and aligns with safe administration standards.",
      "Document the dose as given before administering to save time": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Skip patient education because the medication is routine": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment."
    },
    "case": {
      "tabs": {
        "case_study": "Anti-emetic (ondansetron): scenario involves postop nausea.",
        "vitals": "black tarry stools, HR 112, BP 96/58",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0161",
    "bank": "Pharmacology",
    "topic": "Pharmacology - NSAID",
    "system": "Musculoskeletal",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with ibuprofen? (Select the best response.)",
    "choices": [
      "saline nasal spray with ibuprofen",
      "acetaminophen (standard dosing) with ibuprofen",
      "fiber supplement with ibuprofen",
      "OTC NSAIDs with ibuprofen"
    ],
    "answer": "OTC NSAIDs with ibuprofen",
    "rationale": "High-risk interactions with ibuprofen can cause preventable harm; OTC NSAIDs is concerning because it can increases bleeding/GI risk.",
    "choice_rationales": {
      "saline nasal spray with ibuprofen": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "acetaminophen (standard dosing) with ibuprofen": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "fiber supplement with ibuprofen": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "OTC NSAIDs with ibuprofen": "Correct—OTC NSAIDs can increases bleeding/GI risk when combined with ibuprofen."
    },
    "case": {
      "tabs": {
        "case_study": "NSAID (ibuprofen): scenario involves acute musculoskeletal pain.",
        "vitals": "pain 7/10, HR 96, BP 136/82",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0162",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (macrolide)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting azithromycin? Select all that apply. (Select the best response.)",
    "choices": [
      "Keep an updated medication list and share it at every visit",
      "Store all medications in the bathroom medicine cabinet",
      "report palpitations/syncope",
      "Double the next dose if one is missed",
      "complete therapy",
      "Stop the medication when symptoms improve"
    ],
    "answer": [
      "Keep an updated medication list and share it at every visit",
      "report palpitations/syncope",
      "complete therapy"
    ],
    "rationale": "Teaching for azithromycin must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: report palpitations/syncope, complete therapy.",
    "choice_rationales": {
      "Keep an updated medication list and share it at every visit": "Correct—supports safe self-management and reduces risk.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "report palpitations/syncope": "Correct—supports safe self-management and reduces risk.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "complete therapy": "Correct—supports safe self-management and reduces risk.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (macrolide) (azithromycin): scenario involves community-acquired pneumonia.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start azithromycin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0163",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Insulin (rapid-acting)",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, sliding-scale insulin lispro is ordered: 151–200 = 2 units, 201–250 = 4 units, 251–300 = 6 units, 301–350 = 8 units. What dose should the nurse administer? (Select the best response.)",
    "choices": [
      "4 units",
      "2 units",
      "8 units",
      "6 units"
    ],
    "answer": "2 units",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "4 units": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "2 units": "Correct—calculation and/or unit conversion matches the order.",
      "8 units": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "6 units": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Insulin (rapid-acting) (insulin lispro): scenario involves postprandial hyperglycemia.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "Point-of-care glucose: 178 mg/dL",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start insulin lispro per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0164",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SSRI",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering sertraline requires immediate action?",
    "choices": [
      "dry mouth",
      "GI upset",
      "transient nausea",
      "sleepiness after taking the dose"
    ],
    "answer": "GI upset",
    "rationale": "High-risk adverse reactions to sertraline include GI upset, sexual dysfunction, serotonin syndrome (rare). The nurse must respond to GI upset immediately to prevent deterioration.",
    "choice_rationales": {
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "GI upset": "Correct—GI upset is a serious adverse effect associated with sertraline and can progress rapidly if unaddressed.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "SSRI (sertraline): scenario involves major depressive disorder.",
        "vitals": "anxious, HR 126, BP 140/86, RR 22",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0165",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antipsychotic (atypical)",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the olanzapine is achieving the intended therapeutic effect?",
    "choices": [
      "worsening lab abnormalities",
      "no symptom change after several doses",
      "development of rash and wheeze",
      "symptom improvement with stable vital signs and target lab trends"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (acute mania). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication."
    },
    "case": {
      "tabs": {
        "case_study": "Antipsychotic (atypical) (olanzapine): scenario involves acute mania.",
        "vitals": "anxious, HR 126, BP 140/86, RR 22",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0166",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Sulfonylurea",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold glipizide and notify the provider? Select all that apply. (Select the best response.)",
    "choices": [
      "Afebrile temperature 36.8°C (98.2°F)",
      "DKA",
      "Reports mild nausea",
      "type 1 diabetes",
      "Pain 4/10 relieved with repositioning",
      "BP 138/84 without symptoms"
    ],
    "answer": [
      "DKA",
      "type 1 diabetes"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for glipizide plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "DKA": "Correct—requires holding due to safety risk/contraindication.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "type 1 diabetes": "Correct—requires holding due to safety risk/contraindication.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Sulfonylurea (glipizide): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0167",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting metformin? Select all that apply. (Select the best response.)",
    "choices": [
      "Call the clinic before starting any OTC/herbal products",
      "Stop the medication when symptoms improve",
      "Share prescription medications with family members if they have similar symptoms",
      "Store all medications in the bathroom medicine cabinet",
      "hold for iodinated contrast if ordered",
      "take with food"
    ],
    "answer": [
      "Call the clinic before starting any OTC/herbal products",
      "hold for iodinated contrast if ordered",
      "take with food"
    ],
    "rationale": "Teaching for metformin must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: take with food, hold for iodinated contrast if ordered.",
    "choice_rationales": {
      "Call the clinic before starting any OTC/herbal products": "Correct—supports safe self-management and reduces risk.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "hold for iodinated contrast if ordered": "Correct—supports safe self-management and reduces risk.",
      "take with food": "Correct—supports safe self-management and reduces risk."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0168",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Immunization",
    "system": "Community/Public Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, influenza vaccine is prescribed at 15 mg/kg/dose. The child weighs 22 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "180.0 mg",
      "155.0 mg",
      "120.0 mg",
      "150.0 mg"
    ],
    "answer": "150.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "180.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "155.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "150.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 22 lb.",
        "vitals": "afebrile, HR 84, BP 124/78",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0169",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Inhaled corticosteroid",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering fluticasone requires immediate action?",
    "choices": [
      "sleepiness after taking the dose",
      "transient nausea",
      "dry mouth",
      "hoarseness"
    ],
    "answer": "hoarseness",
    "rationale": "High-risk adverse reactions to fluticasone include candidiasis, hoarseness. The nurse must respond to hoarseness immediately to prevent deterioration.",
    "choice_rationales": {
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "hoarseness": "Correct—hoarseness is a serious adverse effect associated with fluticasone and can progress rapidly if unaddressed."
    },
    "case": {
      "tabs": {
        "case_study": "Inhaled corticosteroid (fluticasone): scenario involves asthma control.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0170",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the oxytocin is achieving the intended therapeutic effect?",
    "choices": [
      "development of rash and wheeze",
      "symptom improvement with stable vital signs and target lab trends",
      "no symptom change after several doses",
      "new onset dizziness when standing"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (induction/augmentation of labor). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "uterine contractions q1 min, FHR late decels",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0171",
    "bank": "Pharmacology",
    "topic": "Pharmacology - NSAID",
    "system": "Musculoskeletal",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the ibuprofen order? (Select the best response.)",
    "choices": [
      "Skip patient education because the medication is routine",
      "Give the medication first and then check the client’s vitals",
      "Document the dose as given before administering to save time",
      "Assess the parameter that determines whether to hold the medication (per protocol) before giving"
    ],
    "answer": "Assess the parameter that determines whether to hold the medication (per protocol) before giving",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering ibuprofen.",
    "choice_rationales": {
      "Skip patient education because the medication is routine": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Give the medication first and then check the client’s vitals": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Document the dose as given before administering to save time": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Assess the parameter that determines whether to hold the medication (per protocol) before giving": "Correct—this action prevents a medication error and aligns with safe administration standards."
    },
    "case": {
      "tabs": {
        "case_study": "NSAID (ibuprofen): scenario involves acute musculoskeletal pain.",
        "vitals": "epigastric burning, HR 102, BP 128/78",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0172",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the metformin is achieving the intended therapeutic effect? (Select the best response.)",
    "choices": [
      "new onset dizziness when standing",
      "no symptom change after several doses",
      "development of rash and wheeze",
      "symptom improvement with stable vital signs and target lab trends"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (type 2 diabetes). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start metformin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0173",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Opioid analgesic",
    "system": "Perioperative/Critical Care",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold morphine and notify the provider? Select all that apply. (Select the best response.)",
    "choices": [
      "BP 138/84 without symptoms",
      "Reports mild nausea",
      "respiratory depression",
      "Pain 4/10 relieved with repositioning",
      "acute severe asthma",
      "HR 46/min with dizziness"
    ],
    "answer": [
      "respiratory depression",
      "acute severe asthma",
      "HR 46/min with dizziness"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for morphine plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "respiratory depression": "Correct—requires holding due to safety risk/contraindication.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "acute severe asthma": "Correct—requires holding due to safety risk/contraindication.",
      "HR 46/min with dizziness": "Correct—requires holding due to safety risk/contraindication."
    },
    "case": {
      "tabs": {
        "case_study": "Opioid analgesic (morphine): scenario involves severe postoperative pain.",
        "vitals": "RR 8, SpO2 90% on 2L NC, HR 58, BP 86/48",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0174",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SABA bronchodilator",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving albuterol. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Offer only ice chips and reassess in 6 hours",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Avoid documenting to prevent alarming the client",
      "Document the reaction and update the allergy list per policy",
      "Give the next dose early to overcome the reaction"
    ],
    "answer": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Document the reaction and update the allergy list per policy"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Give the next dose early to overcome the reaction": "Incorrect—unsafe and does not manage the reaction."
    },
    "case": {
      "tabs": {
        "case_study": "SABA bronchodilator (albuterol): scenario involves acute bronchospasm.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start albuterol per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0175",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with oxytocin?",
    "choices": [
      "alcohol use with oxytocin",
      "multivitamin with oxytocin",
      "acetaminophen (standard dosing) with oxytocin",
      "fiber supplement with oxytocin"
    ],
    "answer": "alcohol use with oxytocin",
    "rationale": "High-risk interactions with oxytocin can cause preventable harm; alcohol use is concerning because it can increases adverse effects.",
    "choice_rationales": {
      "alcohol use with oxytocin": "Correct—alcohol use can increases adverse effects when combined with oxytocin.",
      "multivitamin with oxytocin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "acetaminophen (standard dosing) with oxytocin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "fiber supplement with oxytocin": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start oxytocin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0176",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SABA bronchodilator",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the albuterol is achieving the intended therapeutic effect?",
    "choices": [
      "symptom improvement with stable vital signs and target lab trends",
      "no symptom change after several doses",
      "development of rash and wheeze",
      "new onset dizziness when standing"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (acute bronchospasm). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "SABA bronchodilator (albuterol): scenario involves acute bronchospasm.",
        "vitals": "RR 28, SpO2 88% RA, HR 110, BP 142/86",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0177",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Inhaled corticosteroid",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the fluticasone order before administering?",
    "choices": [
      "headache rated 3/10",
      "mild nausea after breakfast",
      "acute bronchospasm",
      "last bowel movement yesterday"
    ],
    "answer": "acute bronchospasm",
    "rationale": "fluticasone should be questioned when acute bronchospasm is present because it can precipitate severe adverse outcomes (e.g., candidiasis, hoarseness).",
    "choice_rationales": {
      "headache rated 3/10": "Not the best—headache rated 3/10 does not directly contraindicate fluticasone in this scenario.",
      "mild nausea after breakfast": "Not the best—mild nausea after breakfast does not directly contraindicate fluticasone in this scenario.",
      "acute bronchospasm": "Correct—acute bronchospasm is a contraindication/major caution for fluticasone and increases risk of serious harm.",
      "last bowel movement yesterday": "Not the best—last bowel movement yesterday does not directly contraindicate fluticasone in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Inhaled corticosteroid (fluticasone): scenario involves asthma control.",
        "vitals": "RR 28, SpO2 88% RA, HR 110, BP 142/86",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0178",
    "bank": "Pharmacology",
    "topic": "Pharmacology - TB therapy",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the isoniazid is achieving the intended therapeutic effect? (Select the best response.)",
    "choices": [
      "new onset dizziness when standing",
      "development of rash and wheeze",
      "symptom improvement with stable vital signs and target lab trends",
      "no symptom change after several doses"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (latent TB infection). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "TB therapy (isoniazid): scenario involves latent TB infection.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "AST/ALT elevated; reports numbness/tingling",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start isoniazid per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0179",
    "bank": "Pharmacology",
    "topic": "Pharmacology - IV potassium",
    "system": "Fluids & Electrolytes/Acid-Base",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting potassium chloride? Select all that apply.",
    "choices": [
      "Double the next dose if one is missed",
      "Use teach-back to confirm understanding of dosing schedule",
      "ensure pump and dilution",
      "never IV push",
      "Store all medications in the bathroom medicine cabinet",
      "Share prescription medications with family members if they have similar symptoms"
    ],
    "answer": [
      "Use teach-back to confirm understanding of dosing schedule",
      "ensure pump and dilution",
      "never IV push"
    ],
    "rationale": "Teaching for potassium chloride must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: never IV push, ensure pump and dilution.",
    "choice_rationales": {
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "ensure pump and dilution": "Correct—supports safe self-management and reduces risk.",
      "never IV push": "Correct—supports safe self-management and reduces risk.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "IV potassium (potassium chloride): scenario involves symptomatic hypokalemia.",
        "vitals": "K 2.9 mEq/L, HR 118 with PVCs, BP 104/62",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0180",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving oxytocin? (Select the best response.)",
    "choices": [
      "pupil size",
      "bowel sounds",
      "capillary refill",
      "uterine tachysystole"
    ],
    "answer": "uterine tachysystole",
    "rationale": "The key monitoring for oxytocin includes uterine tachysystole, FHR, I&O; in this case, uterine tachysystole is the most safety-critical.",
    "choice_rationales": {
      "pupil size": "Less relevant—pupil size is not the priority parameter for oxytocin safety/efficacy.",
      "bowel sounds": "Less relevant—bowel sounds is not the priority parameter for oxytocin safety/efficacy.",
      "capillary refill": "Less relevant—capillary refill is not the priority parameter for oxytocin safety/efficacy.",
      "uterine tachysystole": "Correct—monitoring uterine tachysystole detects early complications of oxytocin and guides safety/therapeutic response."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "uterine contractions q1 min, FHR late decels",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0181",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antipsychotic (atypical)",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving olanzapine. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Document the reaction and update the allergy list per policy",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Offer only ice chips and reassess in 6 hours",
      "Send the client home because reactions usually resolve without treatment",
      "Give the next dose early to overcome the reaction"
    ],
    "answer": [
      "Document the reaction and update the allergy list per policy",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Send the client home because reactions usually resolve without treatment": "Incorrect—unsafe and does not manage the reaction.",
      "Give the next dose early to overcome the reaction": "Incorrect—unsafe and does not manage the reaction."
    },
    "case": {
      "tabs": {
        "case_study": "Antipsychotic (atypical) (olanzapine): scenario involves acute mania.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0182",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with oxytocin? Select all that apply.",
    "choices": [
      "Humidifier use",
      "Probiotic yogurt",
      "Opioid use while sedated",
      "Another QT-prolonging medication",
      "Topical moisturizer",
      "Herbal supplement (St. John's wort)"
    ],
    "answer": [
      "Opioid use while sedated",
      "Another QT-prolonging medication",
      "Herbal supplement (St. John's wort)"
    ],
    "rationale": "For oxytocin, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Herbal supplement (St. John's wort)": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start oxytocin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0183",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Anti-emetic",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with ondansetron? Select all that apply. (Select the best response.)",
    "choices": [
      "Topical moisturizer",
      "Opioid use while sedated",
      "Warm compresses",
      "Potassium-containing salt substitute",
      "Humidifier use",
      "Another QT-prolonging medication"
    ],
    "answer": [
      "Opioid use while sedated",
      "Potassium-containing salt substitute",
      "Another QT-prolonging medication"
    ],
    "rationale": "For ondansetron, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Warm compresses": "Incorrect—minimal interaction risk.",
      "Potassium-containing salt substitute": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Anti-emetic (ondansetron): scenario involves postop nausea.",
        "vitals": "N/V, HR 98, BP 122/74, dry mucosa",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0184",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Immunization",
    "system": "Community/Public Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, influenza vaccine is prescribed at 15 mg/kg/dose. The child weighs 33 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "180.0 mg",
      "225.0 mg",
      "230.0 mg",
      "270.0 mg"
    ],
    "answer": "225.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "180.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "225.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "230.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "270.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 33 lb.",
        "vitals": "low-grade fever 37.8°C (100°F), HR 92",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0185",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold warfarin and notify the provider? Select all that apply.",
    "choices": [
      "Afebrile temperature 36.8°C (98.2°F)",
      "pregnancy",
      "active bleeding",
      "Pain 4/10 relieved with repositioning",
      "BP 138/84 without symptoms",
      "Reports mild nausea"
    ],
    "answer": [
      "pregnancy",
      "active bleeding"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for warfarin plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "pregnancy": "Correct—requires holding due to safety risk/contraindication.",
      "active bleeding": "Correct—requires holding due to safety risk/contraindication.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Warfarin (warfarin): scenario involves stroke prevention in atrial fibrillation.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0186",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the metformin is achieving the intended therapeutic effect? (Select the best response.)",
    "choices": [
      "worsening lab abnormalities",
      "new onset dizziness when standing",
      "no symptom change after several doses",
      "symptom improvement with stable vital signs and target lab trends"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (type 2 diabetes). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start metformin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0187",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the oxytocin is achieving the intended therapeutic effect? (Select the best response.)",
    "choices": [
      "worsening lab abnormalities",
      "development of rash and wheeze",
      "symptom improvement with stable vital signs and target lab trends",
      "no symptom change after several doses"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (induction/augmentation of labor). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "uterine contractions q1 min, FHR late decels",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0188",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the warfarin is achieving the intended therapeutic effect?",
    "choices": [
      "no symptom change after several doses",
      "symptom improvement with stable vital signs and target lab trends",
      "development of rash and wheeze",
      "new onset dizziness when standing"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (stroke prevention in atrial fibrillation). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Warfarin (warfarin): scenario involves stroke prevention in atrial fibrillation.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0189",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Magnesium sulfate",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering magnesium sulfate requires immediate action? (Select the best response.)",
    "choices": [
      "mild headache that resolves with rest",
      "dry mouth",
      "respiratory depression",
      "transient nausea"
    ],
    "answer": "respiratory depression",
    "rationale": "High-risk adverse reactions to magnesium sulfate include respiratory depression, loss of DTRs. The nurse must respond to respiratory depression immediately to prevent deterioration.",
    "choice_rationales": {
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "respiratory depression": "Correct—respiratory depression is a serious adverse effect associated with magnesium sulfate and can progress rapidly if unaddressed.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Magnesium sulfate (magnesium sulfate): scenario involves seizure prophylaxis in severe preeclampsia.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "Mg level 7.8 mg/dL; UO 20 mL/hr",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start magnesium sulfate per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0190",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Magnesium sulfate",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the magnesium sulfate order?",
    "choices": [
      "Document the dose as given before administering to save time",
      "Ask the family to decide whether the client wants the medication today",
      "Skip patient education because the medication is routine",
      "Clarify unclear dosing units with the prescriber before preparing the medication"
    ],
    "answer": "Clarify unclear dosing units with the prescriber before preparing the medication",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering magnesium sulfate.",
    "choice_rationales": {
      "Document the dose as given before administering to save time": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Ask the family to decide whether the client wants the medication today": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Skip patient education because the medication is routine": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Clarify unclear dosing units with the prescriber before preparing the medication": "Correct—this action prevents a medication error and aligns with safe administration standards."
    },
    "case": {
      "tabs": {
        "case_study": "Magnesium sulfate (magnesium sulfate): scenario involves seizure prophylaxis in severe preeclampsia.",
        "vitals": "uterine contractions q1 min, FHR late decels",
        "labs": "Mg level 7.8 mg/dL; UO 20 mL/hr",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0191",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (macrolide)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the azithromycin is achieving the intended therapeutic effect?",
    "choices": [
      "new onset dizziness when standing",
      "no symptom change after several doses",
      "symptom improvement with stable vital signs and target lab trends",
      "development of rash and wheeze"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (community-acquired pneumonia). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (macrolide) (azithromycin): scenario involves community-acquired pneumonia.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start azithromycin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0192",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the warfarin order before administering? (Select the best response.)",
    "choices": [
      "pregnancy",
      "mild nausea after breakfast",
      "headache rated 3/10",
      "last bowel movement yesterday"
    ],
    "answer": "pregnancy",
    "rationale": "warfarin should be questioned when pregnancy is present because it can precipitate severe adverse outcomes (e.g., bleeding, skin necrosis (rare)).",
    "choice_rationales": {
      "pregnancy": "Correct—pregnancy is a contraindication/major caution for warfarin and increases risk of serious harm.",
      "mild nausea after breakfast": "Not the best—mild nausea after breakfast does not directly contraindicate warfarin in this scenario.",
      "headache rated 3/10": "Not the best—headache rated 3/10 does not directly contraindicate warfarin in this scenario.",
      "last bowel movement yesterday": "Not the best—last bowel movement yesterday does not directly contraindicate warfarin in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Warfarin (warfarin): scenario involves stroke prevention in atrial fibrillation.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0193",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (macrolide)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with azithromycin? Select all that apply. (Select the best response.)",
    "choices": [
      "OTC NSAIDs used daily",
      "Topical moisturizer",
      "Probiotic yogurt",
      "Humidifier use",
      "Another QT-prolonging medication",
      "Alcohol use (2–3 drinks nightly)"
    ],
    "answer": [
      "OTC NSAIDs used daily",
      "Another QT-prolonging medication",
      "Alcohol use (2–3 drinks nightly)"
    ],
    "rationale": "For azithromycin, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "OTC NSAIDs used daily": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (macrolide) (azithromycin): scenario involves community-acquired pneumonia.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start azithromycin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0194",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with oxytocin? Select all that apply. (Select the best response.)",
    "choices": [
      "Another QT-prolonging medication",
      "Topical moisturizer",
      "Opioid use while sedated",
      "Probiotic yogurt",
      "Alcohol use (2–3 drinks nightly)",
      "Humidifier use"
    ],
    "answer": [
      "Another QT-prolonging medication",
      "Opioid use while sedated",
      "Alcohol use (2–3 drinks nightly)"
    ],
    "rationale": "For oxytocin, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Another QT-prolonging medication": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Humidifier use": "Incorrect—minimal interaction risk."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "uterine contractions q1 min, FHR late decels",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start oxytocin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0195",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antiepileptic",
    "system": "Neurologic",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of phenytoin?",
    "choices": [
      "If I miss a dose, I will double the next dose.",
      "I can take this medication with alcohol to help me sleep.",
      "I will stop the medication as soon as I feel better.",
      "do not stop abruptly"
    ],
    "answer": "do not stop abruptly",
    "rationale": "Key teaching for phenytoin includes: good oral hygiene, do not stop abruptly. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "do not stop abruptly": "Correct—this statement reflects safe, accurate self-management for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "Antiepileptic (phenytoin): scenario involves seizure prevention.",
        "vitals": "GCS 14, pupils equal, HR 88, BP 150/88",
        "labs": "phenytoin level 24 mcg/mL; nystagmus noted",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start phenytoin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0196",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, warfarin is prescribed at 10 mg/kg/dose. The child weighs 33 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.) (Select the best response.)",
    "choices": [
      "155.0 mg",
      "120.0 mg",
      "180.0 mg",
      "150.0 mg"
    ],
    "answer": "150.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "155.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "180.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "150.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 33 lb.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0197",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Thyroid hormone",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving levothyroxine. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Offer only ice chips and reassess in 6 hours",
      "Document the reaction and update the allergy list per policy",
      "Avoid documenting to prevent alarming the client",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Send the client home because reactions usually resolve without treatment",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing"
    ],
    "answer": [
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Send the client home because reactions usually resolve without treatment": "Incorrect—unsafe and does not manage the reaction.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety."
    },
    "case": {
      "tabs": {
        "case_study": "Thyroid hormone (levothyroxine): scenario involves hypothyroidism.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start levothyroxine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0198",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Opioid analgesic",
    "system": "Perioperative/Critical Care",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering morphine requires immediate action?",
    "choices": [
      "dry mouth",
      "transient nausea",
      "constipation",
      "mild headache that resolves with rest"
    ],
    "answer": "constipation",
    "rationale": "High-risk adverse reactions to morphine include respiratory depression, constipation, hypotension. The nurse must respond to constipation immediately to prevent deterioration.",
    "choice_rationales": {
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "constipation": "Correct—constipation is a serious adverse effect associated with morphine and can progress rapidly if unaddressed.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Opioid analgesic (morphine): scenario involves severe postoperative pain.",
        "vitals": "pain 9/10, HR 120, BP 152/88",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start morphine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0199",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antiepileptic",
    "system": "Neurologic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting phenytoin? Select all that apply.",
    "choices": [
      "do not stop abruptly",
      "Share prescription medications with family members if they have similar symptoms",
      "Use teach-back to confirm understanding of dosing schedule",
      "good oral hygiene",
      "Store all medications in the bathroom medicine cabinet",
      "Double the next dose if one is missed"
    ],
    "answer": [
      "do not stop abruptly",
      "Use teach-back to confirm understanding of dosing schedule",
      "good oral hygiene"
    ],
    "rationale": "Teaching for phenytoin must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: good oral hygiene, do not stop abruptly.",
    "choice_rationales": {
      "do not stop abruptly": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "good oral hygiene": "Correct—supports safe self-management and reduces risk.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Antiepileptic (phenytoin): scenario involves seizure prevention.",
        "vitals": "GCS 14, pupils equal, HR 88, BP 150/88",
        "labs": "phenytoin level 24 mcg/mL; nystagmus noted",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0200",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (penicillin)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold amoxicillin and notify the provider? Select all that apply.",
    "choices": [
      "Pain 4/10 relieved with repositioning",
      "BP 138/84 without symptoms",
      "Afebrile temperature 36.8°C (98.2°F)",
      "Reports mild nausea",
      "Asks to take medication with orange juice",
      "anaphylaxis to penicillins"
    ],
    "answer": [
      "anaphylaxis to penicillins"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for amoxicillin plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "anaphylaxis to penicillins": "Correct—requires holding due to safety risk/contraindication."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (penicillin) (amoxicillin): scenario involves strep pharyngitis.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0201",
    "bank": "Pharmacology",
    "topic": "Pharmacology - IV potassium",
    "system": "Fluids & Electrolytes/Acid-Base",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering potassium chloride requires immediate action?",
    "choices": [
      "dry mouth",
      "phlebitis",
      "mild headache that resolves with rest",
      "sleepiness after taking the dose"
    ],
    "answer": "phlebitis",
    "rationale": "High-risk adverse reactions to potassium chloride include arrhythmias, phlebitis, pain at site. The nurse must respond to phlebitis immediately to prevent deterioration.",
    "choice_rationales": {
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "phlebitis": "Correct—phlebitis is a serious adverse effect associated with potassium chloride and can progress rapidly if unaddressed.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "IV potassium (potassium chloride): scenario involves symptomatic hypokalemia.",
        "vitals": "K 5.8 mEq/L, peaked T waves on ECG",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0202",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, oxytocin is prescribed at 5 mg/kg/dose. The child weighs 44 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "80.0 mg",
      "120.0 mg",
      "105.0 mg",
      "100.0 mg"
    ],
    "answer": "100.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "80.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "105.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 44 lb.",
        "vitals": "BP 168/110, RR 20, SpO2 96%, 2+ clonus",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0203",
    "bank": "Pharmacology",
    "topic": "Pharmacology - NSAID",
    "system": "Musculoskeletal",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving ibuprofen?",
    "choices": [
      "temperature",
      "pain score",
      "renal function",
      "urine ketones"
    ],
    "answer": "renal function",
    "rationale": "The key monitoring for ibuprofen includes GI bleeding, renal function; in this case, renal function is the most safety-critical.",
    "choice_rationales": {
      "temperature": "Less relevant—temperature is not the priority parameter for ibuprofen safety/efficacy.",
      "pain score": "Less relevant—pain score is not the priority parameter for ibuprofen safety/efficacy.",
      "renal function": "Correct—monitoring renal function detects early complications of ibuprofen and guides safety/therapeutic response.",
      "urine ketones": "Less relevant—urine ketones is not the priority parameter for ibuprofen safety/efficacy."
    },
    "case": {
      "tabs": {
        "case_study": "NSAID (ibuprofen): scenario involves acute musculoskeletal pain.",
        "vitals": "epigastric burning, HR 102, BP 128/78",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start ibuprofen per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0204",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (macrolide)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold azithromycin and notify the provider? Select all that apply.",
    "choices": [
      "Afebrile temperature 36.8°C (98.2°F)",
      "Pain 4/10 relieved with repositioning",
      "QT prolongation (caution)",
      "BP 138/84 without symptoms",
      "Asks to take medication with orange juice",
      "Reports mild nausea"
    ],
    "answer": [
      "QT prolongation (caution)"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for azithromycin plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "QT prolongation (caution)": "Correct—requires holding due to safety risk/contraindication.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (macrolide) (azithromycin): scenario involves community-acquired pneumonia.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start azithromycin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0205",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SSRI",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, after administering sertraline, which findings should the nurse monitor closely for potential complications? Select all that apply. (Select the best response.)",
    "choices": [
      "increased appetite after meal",
      "mild thirst",
      "serotonin syndrome (rare)",
      "slight fatigue after poor sleep",
      "sexual dysfunction",
      "GI upset"
    ],
    "answer": [
      "serotonin syndrome (rare)",
      "sexual dysfunction",
      "GI upset"
    ],
    "rationale": "Monitoring targets known high-yield adverse effects of sertraline: GI upset, sexual dysfunction, serotonin syndrome (rare).",
    "choice_rationales": {
      "increased appetite after meal": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "mild thirst": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "serotonin syndrome (rare)": "Correct—known complication/adverse effect requiring surveillance.",
      "slight fatigue after poor sleep": "Incorrect—non-specific, not a priority adverse effect for this medication.",
      "sexual dysfunction": "Correct—known complication/adverse effect requiring surveillance.",
      "GI upset": "Correct—known complication/adverse effect requiring surveillance."
    },
    "case": {
      "tabs": {
        "case_study": "SSRI (sertraline): scenario involves major depressive disorder.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0206",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Thyroid hormone",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving levothyroxine. Which nursing interventions are appropriate? Select all that apply. (Select the best response.)",
    "choices": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Offer only ice chips and reassess in 6 hours",
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Send the client home because reactions usually resolve without treatment",
      "Avoid documenting to prevent alarming the client"
    ],
    "answer": [
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Send the client home because reactions usually resolve without treatment": "Incorrect—unsafe and does not manage the reaction.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction."
    },
    "case": {
      "tabs": {
        "case_study": "Thyroid hormone (levothyroxine): scenario involves hypothyroidism.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start levothyroxine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0207",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Inhaled corticosteroid",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, fluticasone is prescribed at 15 mg/kg/dose. The child weighs 22 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "150.0 mg",
      "180.0 mg",
      "155.0 mg",
      "120.0 mg"
    ],
    "answer": "150.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "150.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "180.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "155.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 22 lb.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0208",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antipsychotic (atypical)",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering olanzapine requires immediate action?",
    "choices": [
      "weight gain",
      "sleepiness after taking the dose",
      "dry mouth",
      "transient nausea"
    ],
    "answer": "weight gain",
    "rationale": "High-risk adverse reactions to olanzapine include weight gain, metabolic syndrome, sedation. The nurse must respond to weight gain immediately to prevent deterioration.",
    "choice_rationales": {
      "weight gain": "Correct—weight gain is a serious adverse effect associated with olanzapine and can progress rapidly if unaddressed.",
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "dry mouth": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated."
    },
    "case": {
      "tabs": {
        "case_study": "Antipsychotic (atypical) (olanzapine): scenario involves acute mania.",
        "vitals": "anxious, HR 126, BP 140/86, RR 22",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0209",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SSRI",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which new finding after administering sertraline requires immediate action? (Select the best response.)",
    "choices": [
      "transient nausea",
      "mild headache that resolves with rest",
      "sleepiness after taking the dose",
      "sexual dysfunction"
    ],
    "answer": "sexual dysfunction",
    "rationale": "High-risk adverse reactions to sertraline include GI upset, sexual dysfunction, serotonin syndrome (rare). The nurse must respond to sexual dysfunction immediately to prevent deterioration.",
    "choice_rationales": {
      "transient nausea": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "mild headache that resolves with rest": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "sleepiness after taking the dose": "Not the best—this is a common, non-urgent side effect that can be monitored/supportively treated.",
      "sexual dysfunction": "Correct—sexual dysfunction is a serious adverse effect associated with sertraline and can progress rapidly if unaddressed."
    },
    "case": {
      "tabs": {
        "case_study": "SSRI (sertraline): scenario involves major depressive disorder.",
        "vitals": "anxious, HR 126, BP 140/86, RR 22",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0210",
    "bank": "Pharmacology",
    "topic": "Pharmacology - IV potassium",
    "system": "Fluids & Electrolytes/Acid-Base",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the potassium chloride is achieving the intended therapeutic effect?",
    "choices": [
      "symptom improvement with stable vital signs and target lab trends",
      "worsening lab abnormalities",
      "no symptom change after several doses",
      "new onset dizziness when standing"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (symptomatic hypokalemia). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "new onset dizziness when standing": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "IV potassium (potassium chloride): scenario involves symptomatic hypokalemia.",
        "vitals": "K 2.9 mEq/L, HR 118 with PVCs, BP 104/62",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0211",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SABA bronchodilator",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, the client takes several home medications. Which medication combination is most concerning with albuterol?",
    "choices": [
      "calcium carbonate with albuterol",
      "acetaminophen (standard dosing) with albuterol",
      "alcohol use with albuterol",
      "saline nasal spray with albuterol"
    ],
    "answer": "alcohol use with albuterol",
    "rationale": "High-risk interactions with albuterol can cause preventable harm; alcohol use is concerning because it can increases adverse effects.",
    "choice_rationales": {
      "calcium carbonate with albuterol": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "acetaminophen (standard dosing) with albuterol": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option.",
      "alcohol use with albuterol": "Correct—alcohol use can increases adverse effects when combined with albuterol.",
      "saline nasal spray with albuterol": "Not the best—this combination is not typically the highest-risk interaction compared with the correct option."
    },
    "case": {
      "tabs": {
        "case_study": "SABA bronchodilator (albuterol): scenario involves acute bronchospasm.",
        "vitals": "RR 28, SpO2 88% RA, HR 110, BP 142/86",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0212",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (vancomycin)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with vancomycin? Select all that apply.",
    "choices": [
      "Opioid use while sedated",
      "Probiotic yogurt",
      "Warm compresses",
      "OTC NSAIDs used daily",
      "Topical moisturizer",
      "Alcohol use (2–3 drinks nightly)"
    ],
    "answer": [
      "Opioid use while sedated",
      "OTC NSAIDs used daily",
      "Alcohol use (2–3 drinks nightly)"
    ],
    "rationale": "For vancomycin, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Opioid use while sedated": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Warm compresses": "Incorrect—minimal interaction risk.",
      "OTC NSAIDs used daily": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (vancomycin) (vancomycin): scenario involves MRSA bacteremia.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "Cr 1.6 (up from 1.0); vanc trough 24 mcg/mL",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0213",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Beta blocker",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving metoprolol?",
    "choices": [
      "HR",
      "bowel sounds",
      "daily calorie count",
      "urine ketones"
    ],
    "answer": "HR",
    "rationale": "The key monitoring for metoprolol includes HR, BP, ECG; in this case, HR is the most safety-critical.",
    "choice_rationales": {
      "HR": "Correct—monitoring HR detects early complications of metoprolol and guides safety/therapeutic response.",
      "bowel sounds": "Less relevant—bowel sounds is not the priority parameter for metoprolol safety/efficacy.",
      "daily calorie count": "Less relevant—daily calorie count is not the priority parameter for metoprolol safety/efficacy.",
      "urine ketones": "Less relevant—urine ketones is not the priority parameter for metoprolol safety/efficacy."
    },
    "case": {
      "tabs": {
        "case_study": "Beta blocker (metoprolol): scenario involves rate control in atrial fibrillation.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0214",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Benzodiazepine",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding best indicates the lorazepam is achieving the intended therapeutic effect? (Select the best response.)",
    "choices": [
      "symptom improvement with stable vital signs and target lab trends",
      "development of rash and wheeze",
      "worsening lab abnormalities",
      "no symptom change after several doses"
    ],
    "answer": "symptom improvement with stable vital signs and target lab trends",
    "rationale": "Evaluation focuses on whether outcomes align with the medication’s goal (acute severe anxiety). The best indicator is: symptom improvement with stable vital signs and target lab trends.",
    "choice_rationales": {
      "symptom improvement with stable vital signs and target lab trends": "Correct—this reflects the desired clinical response for the medication’s indication.",
      "development of rash and wheeze": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "worsening lab abnormalities": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect.",
      "no symptom change after several doses": "Not the best—this suggests adverse effects, lack of response, or complication rather than therapeutic effect."
    },
    "case": {
      "tabs": {
        "case_study": "Benzodiazepine (lorazepam): scenario involves acute severe anxiety.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0215",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Heparin (unfractionated)",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, heparin is infusing at 25,000 units in 250 mL D5W. The order is 1,250 units/hr. At what rate (mL/hr) should the nurse set the pump? (Select the best response.)",
    "choices": [
      "11.5 mL/hr",
      "15 mL/hr",
      "10 mL/hr",
      "12.5 mL/hr"
    ],
    "answer": "12.5 mL/hr",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "11.5 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "15 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "10 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "12.5 mL/hr": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Heparin (unfractionated) (heparin): scenario involves DVT treatment.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0216",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of metformin? (Select the best response.)",
    "choices": [
      "I will stop the medication as soon as I feel better.",
      "If I miss a dose, I will double the next dose.",
      "Herbal supplements are always safe with prescriptions.",
      "hold for iodinated contrast if ordered"
    ],
    "answer": "hold for iodinated contrast if ordered",
    "rationale": "Key teaching for metformin includes: take with food, hold for iodinated contrast if ordered. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "hold for iodinated contrast if ordered": "Correct—this statement reflects safe, accurate self-management for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start metformin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0217",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of oxytocin?",
    "choices": [
      "report severe pain; continuous monitoring",
      "I will stop the medication as soon as I feel better.",
      "Herbal supplements are always safe with prescriptions.",
      "I can take this medication with alcohol to help me sleep."
    ],
    "answer": "report severe pain; continuous monitoring",
    "rationale": "Key teaching for oxytocin includes: report severe pain; continuous monitoring. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "report severe pain; continuous monitoring": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "uterine contractions q1 min, FHR late decels",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start oxytocin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0218",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Inhaled corticosteroid",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, what is the nurse’s best first action related to the fluticasone order?",
    "choices": [
      "Verify the order, allergies, and two patient identifiers before administration",
      "Ask the family to decide whether the client wants the medication today",
      "Document the dose as given before administering to save time",
      "Skip patient education because the medication is routine"
    ],
    "answer": "Verify the order, allergies, and two patient identifiers before administration",
    "rationale": "High-alert medication safety requires verification, assessment of hold parameters, and review of contraindications/labs before administering fluticasone.",
    "choice_rationales": {
      "Verify the order, allergies, and two patient identifiers before administration": "Correct—this action prevents a medication error and aligns with safe administration standards.",
      "Ask the family to decide whether the client wants the medication today": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Document the dose as given before administering to save time": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment.",
      "Skip patient education because the medication is routine": "Unsafe/incorrect—this increases risk for error, harm, or omitted assessment."
    },
    "case": {
      "tabs": {
        "case_study": "Inhaled corticosteroid (fluticasone): scenario involves asthma control.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start fluticasone per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0219",
    "bank": "Pharmacology",
    "topic": "Pharmacology - IV potassium",
    "system": "Fluids & Electrolytes/Acid-Base",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, potassium chloride 20 mEq in 100 mL is ordered to infuse over 2 hours. What rate (mL/hr) should the nurse program? (Select the best response.)",
    "choices": [
      "50 mL/hr",
      "75 mL/hr",
      "25 mL/hr",
      "100 mL/hr"
    ],
    "answer": "50 mL/hr",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "50 mL/hr": "Correct—calculation and/or unit conversion matches the order.",
      "75 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "25 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100 mL/hr": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "IV potassium (potassium chloride): scenario involves symptomatic hypokalemia.",
        "vitals": "K 5.8 mEq/L, peaked T waves on ECG",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0220",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold metformin and notify the provider? Select all that apply.",
    "choices": [
      "Reports mild nausea",
      "BP 138/84 without symptoms",
      "eGFR very low",
      "acute metabolic acidosis",
      "Pain 4/10 relieved with repositioning",
      "Asks to take medication with orange juice"
    ],
    "answer": [
      "eGFR very low",
      "acute metabolic acidosis"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for metformin plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "eGFR very low": "Correct—requires holding due to safety risk/contraindication.",
      "acute metabolic acidosis": "Correct—requires holding due to safety risk/contraindication.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Metformin (metformin): scenario involves type 2 diabetes.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start metformin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0221",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Beta blocker",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving metoprolol? (Select the best response.)",
    "choices": [
      "ECG",
      "capillary refill",
      "daily calorie count",
      "temperature"
    ],
    "answer": "ECG",
    "rationale": "The key monitoring for metoprolol includes HR, BP, ECG; in this case, ECG is the most safety-critical.",
    "choice_rationales": {
      "ECG": "Correct—monitoring ECG detects early complications of metoprolol and guides safety/therapeutic response.",
      "capillary refill": "Less relevant—capillary refill is not the priority parameter for metoprolol safety/efficacy.",
      "daily calorie count": "Less relevant—daily calorie count is not the priority parameter for metoprolol safety/efficacy.",
      "temperature": "Less relevant—temperature is not the priority parameter for metoprolol safety/efficacy."
    },
    "case": {
      "tabs": {
        "case_study": "Beta blocker (metoprolol): scenario involves rate control in atrial fibrillation.",
        "vitals": "HR 46, BP 92/58, RR 16, SpO2 95% RA",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0222",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of warfarin?",
    "choices": [
      "keep vitamin K intake consistent",
      "I will stop the medication as soon as I feel better.",
      "I can take this medication with alcohol to help me sleep.",
      "Herbal supplements are always safe with prescriptions."
    ],
    "answer": "keep vitamin K intake consistent",
    "rationale": "Key teaching for warfarin includes: keep vitamin K intake consistent, avoid NSAIDs. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "keep vitamin K intake consistent": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Warfarin (warfarin): scenario involves stroke prevention in atrial fibrillation.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0223",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Metformin",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, metformin is prescribed at 5 mg/kg/dose. The child weighs 44 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "120.0 mg",
      "80.0 mg",
      "105.0 mg",
      "100.0 mg"
    ],
    "answer": "100.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "80.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "105.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 44 lb.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "eGFR 26 mL/min/1.73m²; lactate 3.8 mmol/L",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0224",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SABA bronchodilator",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving albuterol. Which nursing interventions are appropriate? Select all that apply. (Select the best response.)",
    "choices": [
      "Offer only ice chips and reassess in 6 hours",
      "Document the reaction and update the allergy list per policy",
      "Avoid documenting to prevent alarming the client",
      "Give the next dose early to overcome the reaction",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing"
    ],
    "answer": [
      "Document the reaction and update the allergy list per policy",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Offer only ice chips and reassess in 6 hours": "Incorrect—unsafe and does not manage the reaction.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Give the next dose early to overcome the reaction": "Incorrect—unsafe and does not manage the reaction.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety."
    },
    "case": {
      "tabs": {
        "case_study": "SABA bronchodilator (albuterol): scenario involves acute bronchospasm.",
        "vitals": "RR 28, SpO2 88% RA, HR 110, BP 142/86",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0225",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antifungal",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold fluconazole and notify the provider? Select all that apply. (Select the best response.)",
    "choices": [
      "Afebrile temperature 36.8°C (98.2°F)",
      "Pain 4/10 relieved with repositioning",
      "Reports mild nausea",
      "Asks to take medication with orange juice",
      "BP 138/84 without symptoms",
      "QT prolongation (caution)"
    ],
    "answer": [
      "QT prolongation (caution)"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for fluconazole plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario.",
      "Asks to take medication with orange juice": "Incorrect—does not meet hold criteria in this scenario.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "QT prolongation (caution)": "Correct—requires holding due to safety risk/contraindication."
    },
    "case": {
      "tabs": {
        "case_study": "Antifungal (fluconazole): scenario involves vaginal candidiasis.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0226",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Oxytocin",
    "system": "Reproductive/OB",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the oxytocin order before administering?",
    "choices": [
      "history of seasonal allergies (pollen)",
      "uterine rupture risk (relative)",
      "mild nausea after breakfast",
      "headache rated 3/10"
    ],
    "answer": "uterine rupture risk (relative)",
    "rationale": "oxytocin should be questioned when uterine rupture risk (relative) is present because it can precipitate severe adverse outcomes (e.g., uterine tachysystole, water intoxication (rare)).",
    "choice_rationales": {
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate oxytocin in this scenario.",
      "uterine rupture risk (relative)": "Correct—uterine rupture risk (relative) is a contraindication/major caution for oxytocin and increases risk of serious harm.",
      "mild nausea after breakfast": "Not the best—mild nausea after breakfast does not directly contraindicate oxytocin in this scenario.",
      "headache rated 3/10": "Not the best—headache rated 3/10 does not directly contraindicate oxytocin in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Oxytocin (oxytocin): scenario involves induction/augmentation of labor.",
        "vitals": "uterine contractions q1 min, FHR late decels",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0227",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Sulfonylurea",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, glipizide is prescribed at 5 mg/kg/dose. The child weighs 55 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "125.0 mg",
      "130.0 mg",
      "100.0 mg",
      "150.0 mg"
    ],
    "answer": "125.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "125.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "130.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "150.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 55 lb.",
        "vitals": "BG 56 mg/dL, HR 104, BP 128/76, diaphoretic",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0228",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antifungal",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of fluconazole?",
    "choices": [
      "Herbal supplements are always safe with prescriptions.",
      "I can take this medication with alcohol to help me sleep.",
      "report jaundice",
      "I will stop the medication as soon as I feel better."
    ],
    "answer": "report jaundice",
    "rationale": "Key teaching for fluconazole includes: avoid pregnancy unless prescribed, report jaundice. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "report jaundice": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Antifungal (fluconazole): scenario involves vaginal candidiasis.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start fluconazole per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0229",
    "bank": "Pharmacology",
    "topic": "Pharmacology - IV potassium",
    "system": "Fluids & Electrolytes/Acid-Base",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting potassium chloride? Select all that apply. (Select the best response.)",
    "choices": [
      "ensure pump and dilution",
      "Double the next dose if one is missed",
      "Use teach-back to confirm understanding of dosing schedule",
      "Store all medications in the bathroom medicine cabinet",
      "never IV push",
      "Share prescription medications with family members if they have similar symptoms"
    ],
    "answer": [
      "ensure pump and dilution",
      "Use teach-back to confirm understanding of dosing schedule",
      "never IV push"
    ],
    "rationale": "Teaching for potassium chloride must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: never IV push, ensure pump and dilution.",
    "choice_rationales": {
      "ensure pump and dilution": "Correct—supports safe self-management and reduces risk.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "never IV push": "Correct—supports safe self-management and reduces risk.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "IV potassium (potassium chloride): scenario involves symptomatic hypokalemia.",
        "vitals": "K 2.9 mEq/L, HR 118 with PVCs, BP 104/62",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0230",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antipsychotic (atypical)",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving olanzapine?",
    "choices": [
      "pupil size",
      "capillary refill",
      "daily calorie count",
      "weight"
    ],
    "answer": "weight",
    "rationale": "The key monitoring for olanzapine includes weight, glucose/lipids, EPS; in this case, weight is the most safety-critical.",
    "choice_rationales": {
      "pupil size": "Less relevant—pupil size is not the priority parameter for olanzapine safety/efficacy.",
      "capillary refill": "Less relevant—capillary refill is not the priority parameter for olanzapine safety/efficacy.",
      "daily calorie count": "Less relevant—daily calorie count is not the priority parameter for olanzapine safety/efficacy.",
      "weight": "Correct—monitoring weight detects early complications of olanzapine and guides safety/therapeutic response."
    },
    "case": {
      "tabs": {
        "case_study": "Antipsychotic (atypical) (olanzapine): scenario involves acute mania.",
        "vitals": "anxious, HR 126, BP 140/86, RR 22",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start olanzapine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0231",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Corticosteroid (systemic)",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of prednisone?",
    "choices": [
      "If I miss a dose, I will double the next dose.",
      "Herbal supplements are always safe with prescriptions.",
      "I will stop the medication as soon as I feel better.",
      "take with food"
    ],
    "answer": "take with food",
    "rationale": "Key teaching for prednisone includes: take with food, do not stop abruptly after prolonged use. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "take with food": "Correct—this statement reflects safe, accurate self-management for this medication."
    },
    "case": {
      "tabs": {
        "case_study": "Corticosteroid (systemic) (prednisone): scenario involves acute COPD exacerbation.",
        "vitals": "RR 28, SpO2 88% RA, HR 110, BP 142/86",
        "labs": "BG 286 mg/dL; WBC 14.2K",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start prednisone per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0232",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (penicillin)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with amoxicillin? Select all that apply.",
    "choices": [
      "Potassium-containing salt substitute",
      "Alcohol use (2–3 drinks nightly)",
      "Saline eye drops",
      "OTC NSAIDs used daily",
      "Probiotic yogurt",
      "Warm compresses"
    ],
    "answer": [
      "Potassium-containing salt substitute",
      "Alcohol use (2–3 drinks nightly)",
      "OTC NSAIDs used daily"
    ],
    "rationale": "For amoxicillin, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Potassium-containing salt substitute": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Saline eye drops": "Incorrect—minimal interaction risk.",
      "OTC NSAIDs used daily": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Warm compresses": "Incorrect—minimal interaction risk."
    },
    "case": {
      "tabs": {
        "case_study": "Antibiotic (penicillin) (amoxicillin): scenario involves strep pharyngitis.",
        "vitals": "rash and wheeze after first dose, HR 110",
        "labs": "CBC: WBC 18.5K, neutrophils 88%",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0233",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Heparin (unfractionated)",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, the client develops an adverse reaction after receiving heparin. Which nursing interventions are appropriate? Select all that apply.",
    "choices": [
      "Give the next dose early to overcome the reaction",
      "Send the client home because reactions usually resolve without treatment",
      "Avoid documenting to prevent alarming the client",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy"
    ],
    "answer": [
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing",
      "Document the reaction and update the allergy list per policy"
    ],
    "rationale": "Adverse-reaction management prioritizes ABCs, stopping the offending agent, escalation, and preventing future exposure via documentation/allergy updates.",
    "choice_rationales": {
      "Give the next dose early to overcome the reaction": "Incorrect—unsafe and does not manage the reaction.",
      "Send the client home because reactions usually resolve without treatment": "Incorrect—unsafe and does not manage the reaction.",
      "Avoid documenting to prevent alarming the client": "Incorrect—unsafe and does not manage the reaction.",
      "Notify the provider and activate emergency response if signs of anaphylaxis/instability": "Correct—aligns with adverse reaction management and patient safety.",
      "Stop the infusion/hold the next dose per protocol and assess airway/breathing": "Correct—aligns with adverse reaction management and patient safety.",
      "Document the reaction and update the allergy list per policy": "Correct—aligns with adverse reaction management and patient safety."
    },
    "case": {
      "tabs": {
        "case_study": "Heparin (unfractionated) (heparin): scenario involves DVT treatment.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0234",
    "bank": "Pharmacology",
    "topic": "Pharmacology - NSAID",
    "system": "Musculoskeletal",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of ibuprofen?",
    "choices": [
      "Herbal supplements are always safe with prescriptions.",
      "take with food",
      "I will stop the medication as soon as I feel better.",
      "I can take this medication with alcohol to help me sleep."
    ],
    "answer": "take with food",
    "rationale": "Key teaching for ibuprofen includes: take with food, avoid with anticoagulants unless approved. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "take with food": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "NSAID (ibuprofen): scenario involves acute musculoskeletal pain.",
        "vitals": "pain 7/10, HR 96, BP 136/82",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start ibuprofen per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0235",
    "bank": "Pharmacology",
    "topic": "Pharmacology - SABA bronchodilator",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving albuterol?",
    "choices": [
      "bowel sounds",
      "HR",
      "daily calorie count",
      "urine ketones"
    ],
    "answer": "HR",
    "rationale": "The key monitoring for albuterol includes HR, wheezing relief; in this case, HR is the most safety-critical.",
    "choice_rationales": {
      "bowel sounds": "Less relevant—bowel sounds is not the priority parameter for albuterol safety/efficacy.",
      "HR": "Correct—monitoring HR detects early complications of albuterol and guides safety/therapeutic response.",
      "daily calorie count": "Less relevant—daily calorie count is not the priority parameter for albuterol safety/efficacy.",
      "urine ketones": "Less relevant—urine ketones is not the priority parameter for albuterol safety/efficacy."
    },
    "case": {
      "tabs": {
        "case_study": "SABA bronchodilator (albuterol): scenario involves acute bronchospasm.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start albuterol per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0236",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Loop diuretic",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the furosemide order before administering?",
    "choices": [
      "last bowel movement yesterday",
      "mild nausea after breakfast",
      "history of seasonal allergies (pollen)",
      "severe hypovolemia"
    ],
    "answer": "severe hypovolemia",
    "rationale": "furosemide should be questioned when severe hypovolemia is present because it can precipitate severe adverse outcomes (e.g., hypokalemia, ototoxicity (high dose IV)).",
    "choice_rationales": {
      "last bowel movement yesterday": "Not the best—last bowel movement yesterday does not directly contraindicate furosemide in this scenario.",
      "mild nausea after breakfast": "Not the best—mild nausea after breakfast does not directly contraindicate furosemide in this scenario.",
      "history of seasonal allergies (pollen)": "Not the best—history of seasonal allergies (pollen) does not directly contraindicate furosemide in this scenario.",
      "severe hypovolemia": "Correct—severe hypovolemia is a contraindication/major caution for furosemide and increases risk of serious harm."
    },
    "case": {
      "tabs": {
        "case_study": "Loop diuretic (furosemide): scenario involves acute pulmonary edema.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0237",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Direct oral anticoagulant",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, apixaban is prescribed at 15 mg/kg/dose. The child weighs 22 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.)",
    "choices": [
      "120.0 mg",
      "150.0 mg",
      "155.0 mg",
      "180.0 mg"
    ],
    "answer": "150.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "150.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "155.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "180.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 22 lb.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start apixaban per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0238",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antibiotic (vancomycin)",
    "system": "Infectious Diseases/Micro",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, vancomycin is prescribed at 5 mg/kg/dose. The child weighs 55 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.) (Select the best response.)",
    "choices": [
      "150.0 mg",
      "130.0 mg",
      "100.0 mg",
      "125.0 mg"
    ],
    "answer": "125.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "150.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "130.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "100.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "125.0 mg": "Correct—calculation and/or unit conversion matches the order."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 55 lb.",
        "vitals": "T 39.1°C (102.4°F), HR 124, BP 92/54, RR 26",
        "labs": "Cr 1.6 (up from 1.0); vanc trough 24 mcg/mL",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0239",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Antipsychotic (atypical)",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which finding would require the nurse to question the olanzapine order before administering?",
    "choices": [
      "last bowel movement yesterday",
      "headache rated 3/10",
      "BP 138/82 with no symptoms",
      "caution: diabetes"
    ],
    "answer": "caution: diabetes",
    "rationale": "olanzapine should be questioned when caution: diabetes is present because it can precipitate severe adverse outcomes (e.g., weight gain, metabolic syndrome).",
    "choice_rationales": {
      "last bowel movement yesterday": "Not the best—last bowel movement yesterday does not directly contraindicate olanzapine in this scenario.",
      "headache rated 3/10": "Not the best—headache rated 3/10 does not directly contraindicate olanzapine in this scenario.",
      "BP 138/82 with no symptoms": "Not the best—BP 138/82 with no symptoms does not directly contraindicate olanzapine in this scenario.",
      "caution: diabetes": "Correct—caution: diabetes is a contraindication/major caution for olanzapine and increases risk of serious harm."
    },
    "case": {
      "tabs": {
        "case_study": "Antipsychotic (atypical) (olanzapine): scenario involves acute mania.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0240",
    "bank": "Pharmacology",
    "topic": "Pharmacology - ACE inhibitor",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting lisinopril? Select all that apply.",
    "choices": [
      "Stop the medication when symptoms improve",
      "report facial/lip swelling immediately",
      "Double the next dose if one is missed",
      "avoid potassium salt substitutes",
      "Store all medications in the bathroom medicine cabinet",
      "Use teach-back to confirm understanding of dosing schedule"
    ],
    "answer": [
      "report facial/lip swelling immediately",
      "avoid potassium salt substitutes",
      "Use teach-back to confirm understanding of dosing schedule"
    ],
    "rationale": "Teaching for lisinopril must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: rise slowly, avoid potassium salt substitutes.",
    "choice_rationales": {
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "report facial/lip swelling immediately": "Correct—supports safe self-management and reduces risk.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "avoid potassium salt substitutes": "Correct—supports safe self-management and reduces risk.",
      "Store all medications in the bathroom medicine cabinet": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk."
    },
    "case": {
      "tabs": {
        "case_study": "ACE inhibitor (lisinopril): scenario involves hypertension with diabetes.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Telemetry monitoring; repeat BMP/CBC in 6 hours; notify provider for changes"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0241",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Anti-emetic",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of ondansetron?",
    "choices": [
      "report palpitations/dizziness",
      "I can take this medication with alcohol to help me sleep.",
      "If I miss a dose, I will double the next dose.",
      "Herbal supplements are always safe with prescriptions."
    ],
    "answer": "report palpitations/dizziness",
    "rationale": "Key teaching for ondansetron includes: report palpitations/dizziness. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "report palpitations/dizziness": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "I can take this medication with alcohol to help me sleep.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Anti-emetic (ondansetron): scenario involves postop nausea.",
        "vitals": "black tarry stools, HR 112, BP 96/58",
        "labs": "LFTs: AST 86, ALT 92",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start ondansetron per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0242",
    "bank": "Pharmacology",
    "topic": "Pharmacology - IV potassium",
    "system": "Fluids & Electrolytes/Acid-Base",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving potassium chloride?",
    "choices": [
      "pain score",
      "temperature",
      "IV site",
      "capillary refill"
    ],
    "answer": "IV site",
    "rationale": "The key monitoring for potassium chloride includes cardiac rhythm, IV site, serum K; in this case, IV site is the most safety-critical.",
    "choice_rationales": {
      "pain score": "Less relevant—pain score is not the priority parameter for potassium chloride safety/efficacy.",
      "temperature": "Less relevant—temperature is not the priority parameter for potassium chloride safety/efficacy.",
      "IV site": "Correct—monitoring IV site detects early complications of potassium chloride and guides safety/therapeutic response.",
      "capillary refill": "Less relevant—capillary refill is not the priority parameter for potassium chloride safety/efficacy."
    },
    "case": {
      "tabs": {
        "case_study": "IV potassium (potassium chloride): scenario involves symptomatic hypokalemia.",
        "vitals": "K 2.9 mEq/L, HR 118 with PVCs, BP 104/62",
        "labs": "BMP: K 2.9, Mg 1.6, Cr 1.1",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0243",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Benzodiazepine",
    "system": "Psych/Mental Health",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which findings require the nurse to hold lorazepam and notify the provider? Select all that apply.",
    "choices": [
      "severe respiratory insufficiency (caution)",
      "BP 138/84 without symptoms",
      "Pain 4/10 relieved with repositioning",
      "Afebrile temperature 36.8°C (98.2°F)",
      "HR 46/min with dizziness",
      "Reports mild nausea"
    ],
    "answer": [
      "severe respiratory insufficiency (caution)",
      "HR 46/min with dizziness"
    ],
    "rationale": "Hold criteria are based on contraindications and critical parameters for lorazepam plus abnormal monitoring results indicating imminent harm.",
    "choice_rationales": {
      "severe respiratory insufficiency (caution)": "Correct—requires holding due to safety risk/contraindication.",
      "BP 138/84 without symptoms": "Incorrect—does not meet hold criteria in this scenario.",
      "Pain 4/10 relieved with repositioning": "Incorrect—does not meet hold criteria in this scenario.",
      "Afebrile temperature 36.8°C (98.2°F)": "Incorrect—does not meet hold criteria in this scenario.",
      "HR 46/min with dizziness": "Correct—requires holding due to safety risk/contraindication.",
      "Reports mild nausea": "Incorrect—does not meet hold criteria in this scenario."
    },
    "case": {
      "tabs": {
        "case_study": "Benzodiazepine (lorazepam): scenario involves acute severe anxiety.",
        "vitals": "sedated, RR 10, HR 54, BP 88/52",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0244",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Anti-emetic",
    "system": "GI/Hepatic",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with ondansetron? Select all that apply. (Select the best response.)",
    "choices": [
      "OTC NSAIDs used daily",
      "Topical moisturizer",
      "Potassium-containing salt substitute",
      "Humidifier use",
      "Probiotic yogurt",
      "Alcohol use (2–3 drinks nightly)"
    ],
    "answer": [
      "OTC NSAIDs used daily",
      "Potassium-containing salt substitute",
      "Alcohol use (2–3 drinks nightly)"
    ],
    "rationale": "For ondansetron, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "OTC NSAIDs used daily": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Topical moisturizer": "Incorrect—minimal interaction risk.",
      "Potassium-containing salt substitute": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Alcohol use (2–3 drinks nightly)": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Anti-emetic (ondansetron): scenario involves postop nausea.",
        "vitals": "black tarry stools, HR 112, BP 96/58",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0245",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, warfarin is prescribed at 10 mg/kg/dose. The child weighs 33 lb. How many mg per dose should the nurse administer? (Round to nearest tenth.) (Select the best response.)",
    "choices": [
      "120.0 mg",
      "180.0 mg",
      "150.0 mg",
      "155.0 mg"
    ],
    "answer": "150.0 mg",
    "rationale": "Use dimensional analysis: convert units when needed (lb→kg, mg/kg), then compute dose/rate and compare to safe parameters.",
    "choice_rationales": {
      "120.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "180.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion.",
      "150.0 mg": "Correct—calculation and/or unit conversion matches the order.",
      "155.0 mg": "Incorrect—dose/rate is inconsistent with the concentration, time, or weight conversion."
    },
    "case": {
      "tabs": {
        "case_study": "Pediatric dosing: weight 33 lb.",
        "vitals": "oozing at IV site, HR 96, BP 118/72",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0246",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Heparin (unfractionated)",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which concurrent therapies increase the risk of harm when combined with heparin? Select all that apply.",
    "choices": [
      "Potassium-containing salt substitute",
      "Humidifier use",
      "Warm compresses",
      "OTC NSAIDs used daily",
      "Probiotic yogurt",
      "Herbal supplement (St. John's wort)"
    ],
    "answer": [
      "Potassium-containing salt substitute",
      "OTC NSAIDs used daily",
      "Herbal supplement (St. John's wort)"
    ],
    "rationale": "For heparin, additive effects (sedation, bleeding, QT prolongation, electrolyte shifts) are common interaction mechanisms.",
    "choice_rationales": {
      "Potassium-containing salt substitute": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Humidifier use": "Incorrect—minimal interaction risk.",
      "Warm compresses": "Incorrect—minimal interaction risk.",
      "OTC NSAIDs used daily": "Correct—this combination can potentiate toxicity, interaction, or additive effects.",
      "Probiotic yogurt": "Incorrect—minimal interaction risk.",
      "Herbal supplement (St. John's wort)": "Correct—this combination can potentiate toxicity, interaction, or additive effects."
    },
    "case": {
      "tabs": {
        "case_study": "Heparin (unfractionated) (heparin): scenario involves DVT treatment.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Diet order and patient education; follow protocol for adverse reaction management"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0247",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Corticosteroid (systemic)",
    "system": "Respiratory",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of prednisone? (Select the best response.)",
    "choices": [
      "If I miss a dose, I will double the next dose.",
      "take with food",
      "Herbal supplements are always safe with prescriptions.",
      "I will stop the medication as soon as I feel better."
    ],
    "answer": "take with food",
    "rationale": "Key teaching for prednisone includes: take with food, do not stop abruptly after prolonged use. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "take with food": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Corticosteroid (systemic) (prednisone): scenario involves acute COPD exacerbation.",
        "vitals": "RR 10, SpO2 90% on 2L NC, HR 58",
        "labs": "BG 286 mg/dL; WBC 14.2K",
        "nursing_actions": "Assess IV site patency; ensure two identifiers; recheck critical values per policy",
        "md_orders": "Start prednisone per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0248",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Thyroid hormone",
    "system": "Endocrine",
    "difficulty": 5,
    "qtype": "sata",
    "stem": "Using the case information in the tabs, which discharge instructions should the nurse include for a client starting levothyroxine? Select all that apply. (Select the best response.)",
    "choices": [
      "take on empty stomach AM",
      "Use teach-back to confirm understanding of dosing schedule",
      "Stop the medication when symptoms improve",
      "separate from calcium/iron",
      "Double the next dose if one is missed",
      "Share prescription medications with family members if they have similar symptoms"
    ],
    "answer": [
      "take on empty stomach AM",
      "Use teach-back to confirm understanding of dosing schedule",
      "separate from calcium/iron"
    ],
    "rationale": "Teaching for levothyroxine must address safety, adherence, and risk reduction. Correct options include the key medication-specific points: take on empty stomach AM, separate from calcium/iron.",
    "choice_rationales": {
      "take on empty stomach AM": "Correct—supports safe self-management and reduces risk.",
      "Use teach-back to confirm understanding of dosing schedule": "Correct—supports safe self-management and reduces risk.",
      "Stop the medication when symptoms improve": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "separate from calcium/iron": "Correct—supports safe self-management and reduces risk.",
      "Double the next dose if one is missed": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness.",
      "Share prescription medications with family members if they have similar symptoms": "Incorrect—unsafe practice or increases risk for harm/ineffectiveness."
    },
    "case": {
      "tabs": {
        "case_study": "Thyroid hormone (levothyroxine): scenario involves hypothyroidism.",
        "vitals": "BG 410 mg/dL, RR 24, HR 118, BP 96/62",
        "labs": "BMP: Na 128, K 4.9, Cr 1.3",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start levothyroxine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0249",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Calcium channel blocker (dihydropyridine)",
    "system": "Cardiovascular",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which discharge statement by the client indicates correct understanding of amlodipine? (Select the best response.)",
    "choices": [
      "Herbal supplements are always safe with prescriptions.",
      "If I miss a dose, I will double the next dose.",
      "avoid grapefruit if instructed",
      "I will stop the medication as soon as I feel better."
    ],
    "answer": "avoid grapefruit if instructed",
    "rationale": "Key teaching for amlodipine includes: monitor for ankle swelling, avoid grapefruit if instructed. The correct statement demonstrates adherence and safety.",
    "choice_rationales": {
      "Herbal supplements are always safe with prescriptions.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "If I miss a dose, I will double the next dose.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity.",
      "avoid grapefruit if instructed": "Correct—this statement reflects safe, accurate self-management for this medication.",
      "I will stop the medication as soon as I feel better.": "Incorrect—this statement increases risk for adverse effects, treatment failure, or toxicity."
    },
    "case": {
      "tabs": {
        "case_study": "Calcium channel blocker (dihydropyridine) (amlodipine): scenario involves hypertension.",
        "vitals": "HR 112, BP 168/94, RR 18, SpO2 96% RA",
        "labs": "ECG: QTc 520 ms",
        "nursing_actions": "Verify allergies and compare MAR to orders; assess baseline vitals and symptoms",
        "md_orders": "Start amlodipine per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  },
  {
    "id": "PHARM-0250",
    "bank": "Pharmacology",
    "topic": "Pharmacology - Warfarin",
    "system": "Immune/Hematology",
    "difficulty": 5,
    "qtype": "single",
    "stem": "Using the case information in the tabs, which assessment or lab is most important to monitor after giving warfarin?",
    "choices": [
      "skin turgor",
      "urine ketones",
      "temperature",
      "INR"
    ],
    "answer": "INR",
    "rationale": "The key monitoring for warfarin includes INR; in this case, INR is the most safety-critical.",
    "choice_rationales": {
      "skin turgor": "Less relevant—skin turgor is not the priority parameter for warfarin safety/efficacy.",
      "urine ketones": "Less relevant—urine ketones is not the priority parameter for warfarin safety/efficacy.",
      "temperature": "Less relevant—temperature is not the priority parameter for warfarin safety/efficacy.",
      "INR": "Correct—monitoring INR detects early complications of warfarin and guides safety/therapeutic response."
    },
    "case": {
      "tabs": {
        "case_study": "Warfarin (warfarin): scenario involves stroke prevention in atrial fibrillation.",
        "vitals": "HR 104, BP 110/68, RR 20, SpO2 94% RA",
        "labs": "CBC: Hgb 10.8, Plt 210K; Coags: INR 3.8 / aPTT 98 sec (per therapy)",
        "nursing_actions": "Review current meds for interactions; use teach-back for discharge teaching",
        "md_orders": "Start warfarin per order; obtain baseline labs; hold if parameters not met"
      }
    },
    "case_group": null
  }
]